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ZUSAMMENFASSUNG 
 
Unimolekulare Mizellen zeigen aufgrund ihrer vielseitigen Materialeigenschaften 
interessante Anwendungsmöglichkeiten, welche auf ihre kovalent verknüpften Kern-
Schale-Architekturen zurückzuführen sind. Sie können unter anderem als Drug-
Delivery-Systeme verwendet werden. Diese kovalent verknüpften Strukturen 
begünstigen eine erhöhte Stabilität in Lösung im Vergleich zu klassischen Mizellen, 
welche durch Selbstassemblierung von niedermolekularen amphiphilen Molekülen 
gebildet werden. Aufgrund des kovalenten Charakters der unimolekularen Mizellen 
liegt kein dynamisches Gleichgewicht zwischen Mizelle und den amphiphilen 
Molekülen vor. Die chemischen Strukturen solcher Kern-Schale-Architekturen 
basieren insbesondere auf Dendrimeren, hyperverzweigten Polymeren oder 
amphiphilen, sternförmigen Blockcopolymeren. 
In der vorliegenden Arbeit wurde eine neue Stufenwachstumspolymerisation auf Basis 
einer Passerini-Dreikomponentenreaktion (Passerini-3KR) entwickelt, um gezielt 
solche sternförmigen Blockcopolymere herzustellen. Die Passerini-3KR ist aufgrund 
der hohen Ausbeuten und Atomökonomie, der einfach umsetzbaren 
Reaktionsführung, der hundertprozentigen Endgruppentreue und vor allem der großen 
strukturellen Vielfalt der Produkte ein beliebtes Synthesetool in der organischen und 
Polymerchemie. Von großer Wichtigkeit für diese Arbeit war auch, dass bei dieser 
Reaktion die Wahl der Seitengruppen nahezu frei ist, was wiederum die Einstellung 
der Eigenschaften, wie Polarität und Funktionalität im Kern der amphiphilen, 
unimolekularen Mizellen ermöglichte. Zusammen mit der in dieser Arbeit 
beschriebenen Molekulargewichtskontrolle bietet die Passerini-3KR ein einfaches und 
vielfältiges makromolekulares Design.  
Die Molekulargewichtskontrolle konnte durch die Einführung eines monofunktionellen 
irreversiblen Kettentransferreagenzes (ICTA) in den Polymerisationsprozess realisiert 
werden. Durch das Verhältnis von ICTA zu Monomer konnte das Molekulargewicht 
gezielt eingestellt werden (analog zu dem Initiator zu Monomer Verhältnis bei 
lebenden/kontrollierten Polymerisationen, aber mechanistisch vollkommen 
unterschiedlich). Durch die Verwendung eines tri- und tetrafunktionalen ICTA konnten 
mittels der Passerini-3KR auch drei- und vierarmige Sternpolymere hergestellt werden. 
Die daraus erhaltenen Sternpolymere wurden anschließend mit einer wasserlöslichen 
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Polyethylenglycol (PEG)-basierten Schale funktionalisiert, um amphiphile 
Sternblockcopolymere mit unimolekularem, mizellarem Verhalten zu generieren. 
Hierfür wurden die vorhandenen Carbonsäure-Endgruppen der Sternpolymere mit 
einem PEG-Aldehyd und einem Isocyanid bzw. PEG-Isocyanid in einer weiteren 
Passerini-3KR umgesetzt, um so eine wasserlösliche Schale mit und ohne 
Verzweigung am Verknüpfungspunkt der Polymerblöcke zu erhalten. Des Weiteren 
wurde der Einfluss des Molekulargewichtes der PEG-Reste auf das 
Aggregationsverhalten der Sternblockcopolymere in wässriger Lösung untersucht. 
Durch die Anzahl an Wiederholeinheiten im Kern und durch die Wahl unterschiedlicher 
Isocyanide als Seitenketten, sowie durch die Oxidation der Thioether-Funktionen zu 
Sulfonen im Polymerrückgrad, konnte die Polarität und die Mikroumgebung im Kern 
gezielt eingestellt und an die Einkapselung von gewünschten Gastmolekülen 
angepasst werden. Das Aggregationsverhalten in wässriger Lösung, sowie das 
Einschlussverhalten und der Transport verschiedener Farbstoffe wurde sowohl visuell 
oder mittels Dynamischer Lichtstreuung (DLS), als auch mit UV/VIS Spektroskopie 
und Hochleistungsflüssigkeitschromatographie (HPLC) untersucht. In letztgenannten 
Untersuchungen konnte zudem gezeigt werden, dass diese Polymere biokompatibel 
sind und sich für Anwendungen als Drug-Delivery-Systeme eignen, was 
Zelluntersuchungen, sowie die Einkapselung als auch die Freilassung eines 
Wirkstoffes (Azithromycin) bestätigten. 
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ABSTRACT 
 
Due to their versatile material properties based on the covalently linked core-shell 
architectures, unimolecular micelles show interesting applications in drug delivery and 
other applications. These covalently linked structures facilitate the increased stability 
in solution compared to classical micelles, which are formed by self-assembly of low 
molecular weight amphiphilic molecules. Due to the covalent nature of unimolecular 
micelles, there is no dynamic equilibrium between the micelle and the amphiphilic 
molecules. The chemical structure of such unimolecular core-shell architectures is 
based on dendrimers, hyperbranched polymers or amphiphilic star-shaped block 
copolymers. 
In this thesis, a new step-growth polymerization, based on the Passerini three-
component reaction (Passerini-3CR) was developed to produce star-shaped block 
copolymers, is introduced. Due to high yields and atom economy, easy synthesis 
protocols, 100% end-group fidelity and large structural diversity, the Passerini-3CR 
reaction is a popular synthesis tool in organic chemistry as well as in polymer 
chemistry. The almost free choice of side groups within this reaction was of great 
importance for this work, since it enabled the tuning of properties such as polarity and 
functionality in the core of the amphiphilic unimolecular micelles. Together with the 
molecular weight control described in this work, the Passerini-3CR offers a simple and 
versatile macromolecular design. 
Molecular weight control could be realized by introducing a monofunctional irreversible 
chain transfer agent (ICTA) to the polymerization process. The molecular weight could 
then be adjusted through the ratio of ICTA to monomer (similar to the initiator to 
monomer ratio in living/controlled polymerizations, but via a completely different 
mechanism). By using a tri- and tetrafunctional ICTA, three- and four-armed star-
shaped polymers could be prepared via the Passerini-3CR. Afterwards, the resulting 
star-shaped polymers were functionalized with a water-soluble polyethylene glycol 
(PEG)-based shell to obtain amphiphilic star-shaped block copolymers with 
unimolecular micellar behavior. For this purpose, the carboxylic acid end groups of the 
star-shaped polymers were functionalized with a PEG-aldehyde and an isocyanide or 
PEG-isocyanide using another Passerini-3CR to obtain a water-soluble shell with and 
without branching point between the polymer blocks. Furthermore, the influence of the 
molecular weight of the PEG residues on the aggregation behavior of the star-shaped 
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block copolymers in aqueous solution was investigated. By the number of repeating 
units in the core, the choice of different isocyanides as side groups, as well as the 
oxidation of the thioether functions to sulfones in the polymer backbone, the polarity 
and microenvironment in the core could be adjusted. Aggregation behavior, 
encapsulation behavior and transport of various dyes were investigated visually or by 
dynamic light scattering (DLS), UV/VIS spectroscopy and high-performance liquid 
chromatography (HPLC). In addition, recent studies have shown that these polymers 
are biocompatible and suitable for drug delivery applications, impressively confirmed 
by cell examinations and the encapsulation and release of an antibiotic (Azithromycin). 
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1. INTRODUCTION 
 
How does one design a medical drug to make an impact at the right location in the 
body? Customarily, dosage forms such as tablets, capsules or creams affect the 
release of contained drug. In today's dosage forms, only a small portion of the 
administered drug reaches the desired site of activity. The remaining part is 
nonspecifically distributed in the entire body and can occasionally cause side-effects, 
for instance during chemotherapy of cancer tumors. On this account, it should be an 
important aim of pharmaceutical research to develop transport systems that deliver the 
drug to the desired site of activity, more precisely to the disease.[ 1 ] A promising 
approach is the covalent or physically drug binding to nanostructured carrier systems. 
The size of these carrier systems is only a few nanometers and thus much smaller 
(100 to 200 times) than the cells of a human body.[ 2 , 3 ] After injection into the 
bloodstream, nanoparticles are rapidly removed from the blood circulation and 
accumulated in the cells of the mononuclear phagocyte system (MPS).[4] This defense 
system against foreign invaders, such as bacteria, is involved in a variety of cells of 
the liver, spleen, lung, lymph nodes and the bone marrow. Therefore, nanoparticles, 
treated as bacteria due to their small size, are in principle suitable for drug 
transportation specifically into all MPS cells, to release them in a controlled manner.[5, 6] 
These nanostructured carrier systems include, among others, liposomes or micelles.  
A particularly interesting subgroup of classical micelles are unimolecular micelles. The 
possibility of determining the architecture and the dimension in a targeted manner and 
adapt it to specific conditions make this type of micelle so special. There are various 
polymer architectures that can act as unimolecular micelles, discussed in detail in the 
following sections.[ 7 ] Referring to this, mainly amphiphilic star-shaped block 
copolymers are investigated in this work. Since the number and length of the arms can 
be tuned and freely chosen, this architecture type is best suited for the use as 
unimolecular micelle. 
The synthesis of these amphiphilic star-shaped block copolymers will be realized via 
the Passerini three-component reaction (Passerini-3CR). The named reaction is a part 
of the large research field of multicomponent reactions (MCRs). Commonly, MCRs are 
characterized by high yields, simple reaction conditions and high atom economy 
including more than two starting materials.[8] Another important advantage of MCRs is 
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the molecular and modular diversity, which can be reached by the variance of the 
readily available components.[9, 10] In recent years, MCRs have been introduced to the 
field of polymer chemistry. This led to the opportunity of designing defined and highly 
complex macromolecular architectures in a straightforward fashion. Especially the 
Passerini-3CR is a useful tool for the design of such architectures, due to the readily 
available starting materials and easy reaction protocols. With this reaction, 
macromolecules containing a substituted ester- and/or amide backbone can be 
obtained, showing interesting properties for drug delivery systems. All these 
advantages make MCRs and especially the Passerini-3CR to a versatile, highly 
attractive and efficient synthesis tool for drug delivery systems. 
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2. THEORETICAL BACKGROUND 
 
2.1 Multicomponent reactions 
 
The field of multicomponent reactions (MCRs) is a rapidly developing and modern 
research topic in organic and polymer chemistry with a high potential for future 
applications. This type of one-pot reaction uses three or more starting materials to form 
highly complex and defined molecules, containing all or the majority of atoms of the 
reactants.[11, 12] The advantage of these high atom-efficient reactions is the reduction 
of reaction steps and the prevention of intermediates, which have to be purified. The 
group of Wright postulated MCRs as being “ideal” reactions due to their high yields, 
simple reaction conditions, environmentally friendly and readily available compounds, 
as well as the already mentioned high atom-efficiency.[13] These features, combined 
with their modular nature and the simple variation of the components, make MCRs a 
versatile tool for combinatorial chemistry and drug discovery.[14, 15] In general, MCRs 
can be distinguished in three basic reaction mechanisms, due to the reversibility of the 
individual reaction steps, having a major impact on the yield of each MCRs type (Figure 
1). Type I MCRs have to deal with low yields, due to the individual equilibrium 
constants of each reversible step. Within type II MCRs, only the last step is irreversible, 
leading to a shift of the equilibrium towards the product and consequently to higher 
yields. The highest yields can be obtained by type III MCRs including exclusively 
irreversible steps.[12] 
 
 
Figure 1: The three basic types of MCRs.[12] 
2. Theoretical Background 
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Moreover, MCRs can be divided into three categories: non-isocyanide-based MCRs, 
isocyanide based MCRs (IMCRs) and metal-catalyzed MCRs.[16] The first in literature 
described non-isocyanide-based MCR is known as the Strecker three-component 
reaction (S-3CR) from 1850, comprising an aldehyde, ammonia and hydrogen cyanide 
to form an α-amino nitrile (Scheme 1).[17] A subsequent acidic hydrolysis leads to a 
racemic mixture of the corresponding amino acids. Afterwards, several variants were 
developed to obtain enantiopure amino acids.[18, 19] In 1882, Arthur Hantzsch described 
a four-component reaction (H-4CR) to obtain pyridines. Therefore, ammonia, two 
equivalents of a β-ketoester and an aldehyde were reacted to form dihydropyrimidines, 
leading to the corresponding pyridines via a simple oxidation (Scheme 1).[20] Eight 
years later, in 1890, the related pyrrole synthesis was reported by Hantzsch (H-3CR), 
using a β-ketoester, ammonia and α-haloketones (Scheme 1).[21] In 1891, the aza-
analogon of the Hantzsch dihydropyridine synthesis was discovered by Biginelli (B-
3CR). The latter reaction is an acid-catalyzed condensation of an aldehyde component 
with urea, to obtain an imine, subsequently reacting with a β-ketoester. A following 
intramolecular condensation using the second urea-amine, leads to 
dihydropyrimidinones (Scheme 1).[ 22 ] Another literature-known three-component 
reaction was investigated by Mannich (M-3CR) in 1920. He describes the reaction of 
a formaldehyde, an amine and an aldehyde or ketone under acidic conditions, to end 
up with a β-aminocarbonyl. Here, the amine and formaldehyde build the corresponding 
iminium-ion, which is subsequently attacked by the aldehyde- or ketone-component 
(Scheme 1).[23] In 1934, the Bucherer-Bergs reaction was reported, describing the 
reaction of an aldehyde, carboxylic acid, ammonia and hydrogen cyanide to end up 
with hydantoins (Scheme 1).[ 24 , 25 ] The Kabachnik-Fields reaction, based on the 
formation of aminophosphonates using an amine, an oxo-component (aldehyde or 
ketone) and a dialkylphosphate was discovered in 1952 (Scheme 1).[26] A few years 
later, in 1956, Asinger described the reaction of two equivalents of a ketone, ammonia 
and elemental sulfur to obtain thiazolines (Scheme 1).[27] 
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Scheme 1: A selection of historically ordered important non-isocyanide-based 
MCRs.[17-27] 
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In line with the industry standard, the CO-containing metal-catalyzed MCRs are 
especially relevant. One of them was developed by Roelen in 1938, who described the 
hydroformylation of alkenes.[28] One year later, in 1939, Reppe investigated the metal-
catalyzed hydrocarboxylation of alkynes.[29] A recent and valuable carbon monoxide 
containing and metal-catalyzed synthesis in organic chemistry was developed by 
Pauson and Khand in 1971.[30] This [2+2+1]-cycloaddition of an alkyne, an alkene and 
carbon monoxide leads to substituted cyclopentenones. In the following years, many 
catalytic alternatives to the Pauson-Khand reaction were reported.[31, 32] 
 
 
Scheme 2: A selection of historically ordered important metal-catalyzed MCRs.[28-32] 
 
2.2 Isocyanide-based multicomponent reactions 
 
Isocyanide-based MCRs are a very important class of MCRs. The most famous 
representatives cover the Passerini three-component reaction (Passerini-3CR) and the 
Ugi four-component reaction (Ugi-4CR), which will be explained in detail in the 
following chapters. But prior to this, the reactivity, the synthesis and the properties of 
isocyanides will be discussed. 
  2. Theoretical Background 
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2.2.1 Isocyanides 
 
The extraordinary reactivity of isocyanides is based on their two resonance structures 
(Scheme 3). For one of the resonance structures, the stable, formally divalent carbon 
atom can lead to a similar reactivity like it is known from carbenes. The other resonance 
structure exhibits a negatively charged carbon, which is able to react as a nucleophile. 
After the nucleophilic attack, it becomes an electrophile and can therefore be 
nucleophilically attacked. The latter process is called α-addition and is the key step in 
the following described Passerini-3CR and Ugi-4CR. The positively charged nitrogen 
atom in the same resonance structure results in α-acidity, which can be additionally 
increased by electron withdrawing substituents in α-position.[11]  
 
 
Scheme 3: Two different resonance structures of isocyanides.[11] 
 
Under acidic conditions, isocyanides can hydrolyze and form the corresponding 
formamide, whereas in basic media they show outstanding stability.[33] In general, 
isocyanides are used in heterocycle synthesis of imidazoles or oxazoles.[ 34 - 36 ] 
Furthermore, by initiation with Brønstedt or Lewis acids and by decomposition of 
metallo-isocyanide-complexes, isocyanides can be polymerized. Naturally occurring 
isocyanides are derived from amino acids (terrestrial-derived) or are based on 
terpenes (marine-derived, e.g. in sponges).[37, 38] 
In 1859, isocyanides were accidently discovered by Lieke (Scheme 4).[39] Reacting allyl 
iodide with silver cyanide did not lead as expected to allyl nitrile, but to the 
corresponding allyl isocyanide, which was proven by Gautier ten years later, in 1869. 
By hydrolysis, he showed that the corresponding formamide was obtained. In case of 
the nitrile, he would have received the corresponding carboxylic acid.[40] In 1867, 
Hofmann postulated the reaction of a primary amine, chloroform and potassium 
hydroxide to synthesize isocyanides in another approach (Scheme 4 ).[ 41 ] First, 
chloroform and potassium hydroxide form a reactive dichlorocarbene, which is 
attacked by the primary amine leading to an ionic intermediate. After the elimination of 
potassium chloride and water, the isocyanide was obtained. These reaction conditions 
revealed only moderate yields. Therefore, more than 100 years later, Ugi et al. used a 
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biphasic system in the presence of a phase-transfer catalyst to improve the yields.[42] 
The synthesis route, which is nowadays the method of choice, was discovered by Ugi 
in 1958 (Scheme 4).[ 43 ] The dehydration of N-formamides, using phosgene as 
dehydration agent and a base, leads to the required isocyanide. For economic 
reasons, the highly toxic phosgene is still used in industry as dehydration agent, 
whereas in laboratory scale, mainly the less toxic phosphorous(V)oxychloride is 
used.[44-46] The isocyanide synthesis of Ugi was the breakthrough and the reason for 
the rapid development of IMCRs. Recently, in 2015, the group of Dömling introduced 
the Leuckart-Wallach reaction for the synthesis of isocyanides.[ 47 ] This reaction, 
starting from an aldehyde or ketone, leads to N-formamides, which were transferred to 
isocyanides via an in-situ-dehydration, using triphosgene (Scheme 4).[48] 
 
 
Scheme 4: A selection of historically ordered important isocyanide syntheses.[39-47] 
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2.2.2 Passerini three-component reaction (Passerini-3CR) 
 
In 1921, Mario Passerini discovered the Passerini-three-component reaction 
(Passerini-3CR), which combines a carboxylic acid, an oxo component (aldehyde or 
ketone) and an isocyanide to synthesize an α-acyloxycarboxamide.[49] The commonly 
accepted mechanism starts with the activation of the carbonyl component via the 
formation of a hydrogen bonded adduct with the carboxylic acid. In the following key 
step of the mechanism, the α-addition, the oxo-component is nucleophilically attacked 
by the carbon atom of the isocyanide. This carbon atom simultaneously reacts as an 
electrophile with the carboxylic acid. A subsequent intramolecular rearrangement with 
acyl transfer provides the Passerini product (Scheme 5). 
 
 
Scheme 5: Mechanism of the Passerini-3CR using a carboxylic acid, an oxo-
component (aldehyde) and an isocyanide.[50, 51] 
 
The commonly accepted mechanism was proposed by Passerini and later confirmed 
by kinetic investigations of Baker and Ugi in 1951 and 1961.[50, 51] Four years later, in 
1965, Eholzer and his group proposed another mechanism including a protonation of 
the isocyanide by the carboxylic acid as first step.[52] This suggestion was disproved 
and the mechanism proposed by Passerini was confirmed again, but by using a second 
carboxylic acid involved in the mechanism after the α-addition (Scheme 6).[53, 54] Due 
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to these results, obtained by quantum chemical calculations in the gas phase, the 
Passerini-3CR would be seen as a four-component reaction mechanistically or as an 
organo-catalyzed reaction. In general, however, the mechanism is not finally clarified. 
 
 
Scheme 6: Recently proposed mechanism of the Passerini-3CR involving two 
carboxylic acids.[53, 54] 
 
Furthermore, many variations of the Passerini-3CR were reported, replacing carboxylic 
acids with hydrazoic acid, which gives an easy access of substituted tetrazoles 
(Scheme 7, a)).[55, 56] Additionally, carboxylic acids can be substituted byalcohols, 
leading to α-alkoxy amide derivatives (Scheme 7, b))[57-61] and due to the in-situ 
oxidation to the corresponding aldehydes, alcohols can be used as alternatives to 
aldehydes, which is handy due to the difficult synthesis, low availability and limited 
shelf-life of aldehydes.[62] Here, 2-iodoxybenzoic acid (IBX) was used as oxidizing 
agent. Other variations comprise the substitution of the oxo-component with acyl 
isocyanates (Scheme 7, c)) or ketenes (Scheme 7, d)), leading to N,N-diacyloxamides 
or α,γ-diketo-carboxamides.[63, 64] 
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Scheme 7: Variations of the Passerini-3CR using hydrazoic acid a) or alcohols b) 
instead of carboxylic acids and using acyl isocyanates c) or ketenes d) instead of 
aldehydes.[55-64] 
 
The simplest approach of using multicomponent reactions in polymer chemistry is for 
monomer synthesis. On this account, the Passerini-3CR has been described in the 
synthetic route to lactides, for the synthesis of ADMET (acyclic diene metathesis) 
monomers, [65-67] as well as for the synthesis of several acrylates, with a diverse 
substitution pattern.[68] Due to the simple structural variation of the monomers, some 
of the properties of the obtained polymers could be selectively adjusted, which has 
been shown for the upper critical solution temperature (UCST) of polyacrylates.[68] Li 
et al. were able to show the Passerini-3CRs´ suitability for the functionalization of 
polymer chains.[ 69 ] Therewith, a polyethylene glycol (PEG) aldehyde was 
functionalized simultaneously with an alkyne and an ATRP initiator, which were directly 
bound to an isocyanide and to an acid component. The obtained functionalized PEGs 
were excellent candidates for synthesizing miktoarm star-shaped polymers. 
Of particular interest is the purpose of the Passerini-3CR in step growth 
polymerizations. In principle, the use of monomers owing two functional groups (for 
example AA + BB, or AB-type monomers) within a Passerini-3CR led to the formation 
of macrocycles or polymers, analogously to a "classical" polycondensation.[70] For 
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polymer synthesis, there are three potential combinations of two bifunctional and one 
monofunctional components known: a) the combination of a dicarboxylic acid with a 
dialdehyde and an isocyanide,[65] b) the combination of a dicarboxylic acid with a 
diisocyanide and an aldehyde[ 71 ] and c) the combination of a dialdehyde with a 
diisocyanide and a carboxylic acid.[72] Depending on the type of above combinations, 
polyesters or polyamides with functional side chains can be obtained (Scheme 8). 
 
 
Scheme 8: Potential combinations of two bifunctional and one monofunctional 
components, for the synthesis of functional polymers via the Passerini-3CR.[63, 71, 72] 
 
The first described example of a Passerini three-component polymerization (Passerini-
3CP) was developed in 2011 by Meier et al.[65] Long-chain dicarboxylic acids and 
dialdehydes were reacted with different isocyanides to end up with substituted 
polyesters (Scheme 8, a)), reaching high molecular weights (Mn > 50,000 g/mol). 
Herein, the thermal properties of the polymers could be varied by the choice of the 
isocyanides. In 2012, Li et al. described the Passerini-3CR of dicarboxylic acids and 
diisocyanides with aldehydes (Scheme 8, b)).[71] In addition to kinetic studies, 
supporting the step-growth mechanism and reaction optimization, the authors 
described the use of 10-undecenal as aldehyde component, leading to polyesters 
owing double bonds in the side chains, disposed for further modification. Making use 
  2. Theoretical Background 
 
 
13 
of alcohols instead of aldehydes in an oxidative Passerini reaction, as it is known from 
organic synthesis, seemed to be ineffective due to the low molecular weights 
achieved.[72, 73] The third potential combination (Scheme 8, c)), investigated by the 
group of Li again, showed that only by the excess of the monofunctional component 
(here the acid component) higher molecular weights could be reached.[72] 
In addition to the above-mentioned examples, it is also possible to use AB-type 
monomers in a Passerini-3CP, leading to a simpler and more efficient (only two 
component) polymerization process. In principle, there are also three possibilities for 
AB-type monomers, whereas isocyanides show a low acid stability, which excludes its 
combination. The combination of an acid and an aldehyde function in an AB-type 
monomer thus seems to be the best choice, since the synthesis of isocyanides requires 
several steps. The one-step synthesis of such an AB-type monomer and its 
polymerization with different isocyanides was intensely investigated by the group of 
Meier (Scheme 9, a)). Interestingly, the thermal properties of those polymers were 
controlled not only by the choice of the isocyanide, but also by the oxidation of the 
sulfide to sulfone in the polymer backbone, which increased the glass transition by 
about 30 °C.[74] Li et al. investigated 4-oxobutyric acid as analogous AB-type monomer 
(Scheme 9, b)).[75] However, mainly ring closing to the γ-butyrolactone was observed. 
The original polymer structure targets were only obtained by using α, β-unsaturated 4-
oxobutyric acid as AB-type monomer and subsequent hydrogenation, in moderate 
molecular weights (< 10,000 g/mol). 
 
 
Scheme 9: Passerini-3CR using an AB-type monomer and an isocyanide.[74, 75] 
 
Recently, Li and his group investigated a Passerini-3CR of 6-oxohexanoic acid using 
different isocyanides leading to functional poly(caprolactone)s (Scheme 10).[76] The 
2. Theoretical Background 
 
 
14 
obtained functional polymers beared tunable amide-linked side groups at the 
ε-position. Furthermore, the copolymerization using the same AB-type monomer was 
successfully demonstrated. Therefore, a mixture of two isocyanides was used in 
different molar ratios. Afterwards, a thiol-ene addition reaction using a thiol-glucose on 
the homopolymer containing alkenyl groups was demonstrated to modify the polymer 
itself. In order to test their compatibility for biomedical applications, their degradation 
and cytotoxicity was investigated. 
 
 
Scheme 10: Synthesis of functional poly(caprolactone)s via the Passerini-3CR of 6-
oxohexanoic using different isocyanides.[76] 
 
Xie and coworkers studied the synthesis of reduction-sensitive amphiphilic copolymers 
via the Passerini-3CR for biomedical applications (Scheme 11).[77] The polymerization 
was performed by using 1,6-diisocyanohexane, 3,3’-dithiodipropionic acid and 
4-(methoxytriethyleneoxy)-carboxybenzaldehyde. Afterwards, the polymer backbone 
was functionalized by introducing hydrophilic ethylene glycol to the side chains. The 
amphiphilic character of the polymer enables the formation of micelles by self-
assembly. Under reductive conditions, involved disulfide bonds were broken and the 
following disassembly of the micelles led to a rearrangement of the hydrophobic 
fragments. Furthermore, these amphiphilic micelles were tested as drug delivery 
systems. Therefore, curcumin, an effective anticancer agent, was encapsulated to 
demonstrate the outstanding encapsulation efficiency and the fast intracellular release. 
Additionally, the micelles showed an excellent biocompatibility, which indicates the 
suitability for drug delivery in anti-cancer therapy of these polymers synthesized by 
Passerini-3CR. 
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Scheme 11: Synthesis of amphiphilic micelles via Passerini-3CR of 1,6-
diisocyanohexane, 3,3’-dithiodipropionic acid and 4-(methoxytriethyleneoxy)-
carboxybenzaldehyde and following encapsulation and release tests of curcumin.[77] 
 
Moreover, polyfunctional monomers have also been used in Passerini-3CRs to obtain 
hyperbranched polymers,[ 78 ] as well as crosslinked hydrogels.[ 79 ] Besides the 
combination of Passerini reactions with photochemistry, e.g. to design photo-
degradable polymers[80], the Passerini reaction was also used for the design of different 
macromolecular architectures. Of particular interest are new approaches focusing on 
dendrimer synthesis[81] (see chapter 2.3) and the design of monodisperse, sequence-
defined macromolecules[82] through Passerini-3CR. 
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2.2.3 Ugi four-component reaction (Ugi-4CR) 
 
Parts of this chapter were published previously: 
A. Llevot, A. C. Boukis, S. Oelmann, K. Wetzel and M. A. R. Meier, Top. Curr. Chem., 
2017, 375, 66. Copyright © 2017, with kind permission from Springer Nature. 
 
The Ugi four-component reaction (Ugi-4CR), discovered by Ivar Karl Ugi in 1959, 
involves the reaction of a carboxylic acid, a ketone or aldehyde, an isocyanide and a 
primary amine as fourth component to generate an α-aminoacylamide under the 
release of water (Scheme 12).[83] The commonly accepted mechanism is initiated by 
the Schiff-base formation of the aldehyde with the amine, which is subsequently 
protonated by the carboxylic acid to form an iminium ion. Then, the lone pair of the 
nucleophilic carbon of the isocyanide attacks the electrophilic center of the iminium 
ion, while concertedly acting as electrophile and reacting with the carboxylic acid (α-
addition). The subsequent intramolecular Mumm rearrangement finally leads to the α-
aminoacylamide.[84]  
 
 
Scheme 12: Overall reaction and mechanism of the Ugi-4CR involving carboxylic acid, 
aldehyde, an isocyanide and a primary amine.[83, 84] 
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The introduction of a fourth component to the Ugi-4CR increases the structural 
diversity and the thermal stability (by the creation of two amide bonds instead of one 
ester and one amide bond) of the final products, in comparison to the Passerini-3CR. 
For the α-addition, there are two possible pathways: An ionic and a non-ionic pathway 
(Scheme 13). The non-ionic pathway describes the reaction of the protonated imine 
with the carboxylic acid anion leading to the hemiaminal and followed by the insertion 
of the isocyanide. In the ionic mechanism of this step, the protonated imine is 
nucleophilically attacked by the isocyanide to form the corresponding nitrilium ion, 
followed by the addition of the carboxylic acid anion. In 2012, the group of Fleurat-
Lessard investigated both pathways and found out, that the ionic mechanism occurs 
only in protic solvents like methanol, due to the imine protonation and the non-ionic 
pathway was only found in the aprotic solvent toluene.[85] 
 
 
Scheme 13: Non-ionic and ionic pathway of the α-addition during the Ugi-4CR.[85] 
 
In the Ugi-4CR, primary amines can be substituted by secondary amines and the 
carboxylic acid component can be replaced by a variety of other components, like 
hydrogen cyanate, thiocarboxylic acids, hydrazoic acid, electron-deficient phenols, 
alcohols and carbon dioxide, which leads to an immense structural diversity.[86-91] One 
of the most known variants of the Ugi reaction is the Ugi-5CR[89] using alcohols and 
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carbon dioxide instead of carboxylic acids to synthesize carbamates (Scheme 14). It 
was published in 1961 by Ugi et al. Another interesting modification of the Ugi reaction 
is the Ugi-Smiles[91] reaction using electron-deficient phenols like nitrophenols or 
quinoline and pyridine derivatives instead of carboxylic acids.[92] The special thing 
about this variant is, that in the last step a Smiles-rearrangement occurs instead of a 
Mumm-rearrangement. The Smiles rearrangement is an intramolecular nucleophilic 
aromatic substitution of an aromatic sulfone, sulfide, ether or other aromatic 
compounds containing electron-withdrawing groups (EWG).[ 93 ] In this way, aryl 
sulfones can be converted to their corresponding sulfonic acids, for example. 
 
 
Scheme 14: Ugi-5CR using methanol and carbon dioxide instead of carboxylic acid to 
synthesize carbamates and Ugi-Smiles reaction using electron-deficient phenols 
instead of carboxylic acid.[87, 89] 
 
The Ugi-4CR was also used in polymer chemistry by synthesizing monomers with 
polymerizable end groups, as direct polymerization method or as post-polymerization 
modification method. In the following part, the focus is on the direct polymerization 
using the Ugi-4CR. Therefore, it is necessary to use two bifunctional and two 
monofunctional components. In recent years, diversely substituted polyamides were 
produced by the Ugi four-component polycondensation process in this way. Via this 
versatile methodology, the possibility to combine different mono- and bi-functional 
components of different nature enables tuning the macromolecular structure of the 
obtained polymers. 
Meier and coworkers investigated the optimal polymerization conditions for the 
combination of two bifunctional and two monofunctional components. This approach 
enables six possible combinations to generate diversely substituted polyamides via the 
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Ugi-4CR (diisocyanide + dialdehyde, diamine + diisocyanide, dialdehyde + diamine, 
diamine + carboxylic diacid, dialdehyde + carboxylic diacid and diisocyanide + 
carboxylic diacid) (Scheme 15).[94] The design of the side groups, as well as the 
repeating units could be tuned by variation of the starting components. The reaction 
conditions were optimized in order to obtain high molar mass polymers. All reactions 
were performed at room temperature for at least 36 h without catalyst. Although Ugi-
4CRs are usually carried out in methanol, the use of different mixtures of 
tetrahydrofuran (THF)/methanol was required in order to prevent the precipitation of 
the polymers during reaction. The concentration also plays an important role in this 
process. Indeed, high dilution led to ring formation, whereas high concentration favored 
polymer formation, as can be expected for a step-growth polymerization. However, too 
high concentration resulted in high viscosity of the reaction mixture, which resulted in 
a decrease of the molar mass of the polymer. Considering all these parameters, Meier 
and coworkers investigated the best THF/methanol mixture and the optimal 
concentration for each of the mentioned combinations. After optimization, polymers 
with a molar mass above 10,000 g/mol were obtained after precipitation for all six 
combinations. Depending on their structure, the polymers showed glass transitions 
ranging from 1 to 65 °C. Furthermore, the mild conditions and tolerance of the Ugi-
4CR towards many functional groups enabled the reaction with an alkyne-containing 
component. The resulting polyamide, bearing terminal alkynes in its side chains, 
offered the opportunity of post-polymerization modifications. The successful coupling 
via azide-alkyne cycloaddition demonstrated possible efficient grafting-onto reactions. 
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Scheme 15: Six possible combinations via the Ugi-4CR using two bifunctional and two 
monofunctional monomers (diisocyanide + dialdehyde (a), dialdehyde + diamine (b), 
dialdehyde + carboxylic diacid (c), diamine + diisocyanide (d), diamine + carboxylic 
diacid (e), and diisocyanide + carboxylic diacid (f)).[94] 
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In addition, Meier and coworkers reported the incorporation of carbon dioxide into 
polymers via the Ugi five component condensation (Ugi-5CC).[95] This reaction is a 
modified version of the Ugi-4CR, with the use of an alcohol (mostly methanol), a 
primary amine, an oxo-component (ketone or aldehyde), an isocyanide and carbon 
dioxide. The Ugi-5CC was employed as direct polymerization method using two 
bifunctional components (1,12-diaminododecane and 1,6-diisocyanohexane), an 
aldehyde, methanol and carbon dioxide to produce polyamides containing methyl 
carbamate side chains (Scheme 16). They could then be further converted into the 
corresponding polyhydantoins using an aqueous potassium hydroxide solution. A 
decrease of glass transition temperature from 37 °C to 0 °C was observed upon 
formation of the polyhydantoin. The molar masses of the synthesized polymers 
reached 20,000 g/mol. Thus, the Ugi-5CC is a novel route to synthesize polyurethanes, 
polycarbonates and polyhydantoins in a straightforward fashion and, moreover, 
catalyst-free way, avoiding the handling of toxic isocyanate or phosgene, commonly 
used in such synthesis. 
 
 
Scheme 16: Polymerization of 1,12-diaminododecane, carbon dioxide, 
1,6-diisocyanohexane and methanol via Ugi-5CC and subsequent treatment with 
potassium hydroxide yielding the corresponding polyhydantoin.[95] 
 
Luxenhofer and coworkers also investigated the six above-mentioned possible 
combinations of components of the Ugi-4CR for the synthesis of polymers bearing 
aromatic moieties in the backbone and side chain (Scheme 17).[96] After screening the 
reaction conditions, most of the combinations led to the formation of oligomers. 
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However, polymers with higher molar masses (between 28,000 g/mol and 
44,000 g/mol) could be prepared for the diisocyanide + dialdehyde combination by 
reacting benzoic acid, hexadecan-1-amine, 1,6-diisocyanohexane and phthalaldehyde 
for five days at room temperature, using N-methyl-2-pyrrolidone (NMP) as solvent 
under argon atmosphere. For the described combination, the polymer backbone is 
formed before the Mumm rearrangement starts, whereas in all other combinations the 
polymer backbone is formed during the Mumm rearrangement, which might be an 
explanation for the better polymerization results.  
 
 
Scheme 17: Polymerization of benzoic acid, hexadecan-1-amine, phtalaldehyde and 
1,6-diisocyanohexane via Ugi-4CR.[96] 
 
Despite its bifunctionality, levulinic acid has to be modified chemically before its 
polymerization. The only example of its direct polymerization was reported by Becer 
and coworkers, who used it in the Ugi-4CR for the synthesis of polyamides (Scheme 
18).[97] By bearing carboxylic acid and ketone moieties in its structure, levulinic acid 
acts as an AB-type monomer in an Ugi-4CR. Two equivalents of levulinic acid were 
reacted with one equivalent of diisocyanide and one equivalent of diamine in a 
microwave reactor at 100 °C in methanol for 30 minutes. 1,6-Diisocyanocyclohexane 
was chosen as diisocyanide and varying diamines have been tested. The use of 
ethylenediamine led to polymers with a molar mass of 8,000 g/mol, and the use of 
longer chain diamines, such as hexamethylenediamine or 1,12-diaminododecane 
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yielded polymers with molar masses up to 12,000 g/mol. A secondary amine 
(spermine) could also be used as a building block in the modified Ugi-4CR. The 
polymerization with a triamine (tris(2-aminoethyl)amine) resulted in a crosslinked 
spongy material and the use of an aromatic diamine (p-phenylenediamine) mainly 
yielded oligomers or macrocycles. Depending on the length of the employed amine, 
the levulinic acid derived polymers exhibited a Tg ranging from 52 to 120 °C. 
 
 
Scheme 18: Polymerization of levulinic acid, 1,6-diisocyclohexane and various 
diamines via Ugi-4CR.[97] 
 
In a similar strategy, Tao, Wang and coworkers evaluated for the first time the use of 
natural amino acids in the Ugi-4CR for the synthesis of structurally diverse 
polypeptoids.[98] Amino acids, containing both carboxylic acid and amino groups in their 
structures, are prominent to be used as AB-type monomers for Ugi-4CR (Scheme 19). 
The combination with additional aldehydes and isocyanides results in polypeptoid 
structures with polyamide and substitution on the amide nitrogen. Although the 
polymerization of α-amino acids, such as glycine or alanine, was unsuccessful due to 
the formation of a six-membered ring as intermediate, lysine, which contains two amino 
groups including an ε-amino group at a higher “distance” to the α-carboxyl group, 
enabled the polymerization. After the protection of the α-amino group with tert-
butyloxycarbonyl (Boc) protecting group, the AB-type monomer reacted with 
benzaldehyde and tert-butyl isocyanide at room temperature for 96 hours in methanol. 
Subsequently, the Boc protecting groups were cleaved to obtain the deprotected 
polypeptoids, reaching molar masses up to 11,000 g/mol. The obtained polymer 
displays an amphiphilic character and can therefore be self-assembled into 
nanoparticles in an aqueous environment in order to be investigated as carrier for drug 
delivery. In this context, the polymer proved to be biocompatible and to exhibit 
antibacterial properties. In similar procedures, L-glutamic acid methyl ester and Nα-
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Boc-L-ornithine reacted with benzaldehyde and tert-butyl isocyanide to prepare poly(γ-
peptoid)s and poly(δ-peptoid)s. Additionally, this strategy gave the opportunity to 
introduce functional groups into polypeptoids, such as alkenes or fluorescent moieties 
by variation the aldehyde structure. 
 
 
Scheme 19: Polymerization of amino acids with benzaldehyde and tert-butyl 
isocyanide via Ugi-4CR.[98] 
 
2.3 Architecture control via multicomponent reactions 
 
Parts of this chapter were published previously: 
A. Llevot, A. C. Boukis, S. Oelmann, K. Wetzel and M. A. R. Meier, Top. Curr. Chem., 
2017, 375, 66. Copyright © 2017, with kind permission from Springer Nature. 
 
The synthesis of well-defined polymer architectures is a topic of high interest. 
Multicomponent reactions revealed to be a powerful tool for the synthesis of such 
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architectures, due to their modular nature, efficiency and the relatively simple reaction 
conditions.[99] 
For instance, dendrimers are an important class of highly-defined macromolecules, 
benefiting from their monodispersity and high functionality. Their synthesis can be 
performed by two main approaches: the divergent and the convergent pathway. The 
divergent synthesis of dendrimers consists in using a multifunctional core, in which 
each functional group reacts with one novel unit. The added groups display new 
functionalities available for further addition of a new unit. This sequence is repeated 
until the dendrimer reaches the desired size.  
Wessjohann et al. described a divergent synthesis by using the Passerini-3CR of 
monoprotected bifunctional isocyanides, aldehydes and carboxylic acids to obtain a 
three-armed core unit with terminal benzyl esters.[100, 101] After cleaving the protecting 
groups via hydrogenation to the corresponding carboxylic acid and repeating these two 
steps (Passerini-3CR and hydrogenation), dendrimers of the third generation were 
received. This concept was extended using more building blocks via the Ugi-
4CR.[100, 101] The same idea of using monoprotected bifunctional components led to a 
core unit with four methyl ester protected branches. The use of a large range of building 
blocks and different protecting groups offered the opportunity of selectively 
functionalized branches. Furthermore, the degree of branching was controlled by using 
monofunctional building blocks. 
In another divergent approach, castor oil-derived chemicals (10-undecenal, 10-
undecenoic acid and 10-isocyanodec-1-ene) containing a terminal double bond were 
used in a Passerini-3CR to form a core unit (Scheme 20).[102] Afterwards, the three 
terminal olefins were reacted in a cross-metathesis reaction with tert-butyl acrylate. 
Hydrogenation of the newly formed double bonds and formation of the introduced tert-
butyl esters to carboxylic acid groups allowed further Passerini-3CRs. Repeating this 
protocol led to the formation of a third-generation dendrimer. The group of Li replaced 
the olefin cross-metathesis reaction with a thiol-yne reaction to introduce terminal 
alkynes, which resulted in additional branching.[103] This simple change led to a higher 
structural diversity within the dendrimers. 
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Scheme 20: Synthesis of divergent dendrimers from castor oil-derived chemicals.[102] 
 
In a convergent synthesis, different precursors (dendrons), often built from small 
molecules, react to form the core of the dendrimer (Scheme 21). 
In 2012, Rudick and coworkers described, for the first time, the convergent synthesis 
of dendrimers using Passerini-3CR.[104] They synthesized second generation dendrons 
with an alcohol end group at the center, which was used as platform for the synthesis 
of the three Passerini precursors (aldehyde, carboxylic acid, isocyanide). The three 
resulting dendrons were then coupled into one dendrimer via Passerini-3CR (Scheme 
21). However, this approach suffered from long reaction times and from the lack of 
reactivity of the dendrons. In order to solve this issue, the authors further investigated 
this reaction by introducing an unbranched linker in order to increase the distance 
between the reactive groups and the branching point, thus decreasing the steric 
interactions between the reagents.[105] As expected, the use of dendrons with poly(alkyl 
ether) spacers exhibited a very short reaction time in the Passerini-3CR. However, the 
authors demonstrated that the reason for the observed increased reactivity does not 
lie in the decrease of the steric hindrance but in an unexpected electronic effect. 
Indeed, the increase of the aldehyde electrophilicity through the presence of strong 
electron-withdrawing substituents, revealed to be the key factor of the accelerating 
effect. Under these conditions, the reaction time could be reduced from 65 or 72 hours 
for not activated components to 24 hours employing the activated aldehyde (for the 
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second generation dendrons). Moreover, the authors showed that the reaction time of 
the Passerini-3CR increased with increasing generation.  
 
 
Scheme 21: Convergent synthesis of dendrimers using Passerini-3CR.[104, 105] 
 
The synthesis of copolymers with defined architecture is also an important field of 
macromolecular engineering. For this purpose, both Passerini-3CR and Ugi-4CR have 
already been investigated.  
The synthesis of Passerini-derived graft copolymers was investigated by the group of 
Li.[ 106 ] Therefore, adipaldehyde, 1,6-diisocyanohexane and 2-bromoisobutyric acid 
reacted in a Passerini-3CR to a polymer containing a polyamide backbone with 
pending hydroxyl groups or atom-transfer radical polymerization (ATRP) initiators. A 
subsequent ring-opening polymerization of ε-caprolactone or ATRP of methyl 
methacrylate and N-isopropylacrylamide led to copolymers. The authors also reported 
on the functionalization of PEG with an ATRP initiator and an alkynyl group by 
Passerini-3CR as precursors for miktoarm terpolymers (Scheme 22).[107]  
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Scheme 22: Synthesis of graft copolymers via Passerini-3CR followed by ring-opening 
polymerization (ROP) or atom-transfer radical polymerization (ATRP).[106, 107] 
 
Tao and coworkers investigated a conjugation method via the Ugi-4CR of 
benzaldehyde-terminated PMMA and aniline-terminated PEG, using an excess of 
functional isocyanides and carboxylic acids to obtain a mid-vinyl PMMA-b-PEG 
polymer.[108] Furthermore, they transformed this linear copolymer into a miktoarm star-
shaped copolymer by introducing a RAFT agent for grafting-from with 
N-isopropylacrylamide (NIPAM).[109] Afterwards, a protein reactive functionality was 
introduced in the polymer backbone in the same manner to PEGylate a protein, which 
led to an improve of pharmacological and biologic activity.[110, 111] The incorporation of 
fluorescent molecules using the Ugi-4CR was also tested. 
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2.4 Unimolecular micelles 
 
Unimolecular micelles possess interesting material properties due to their architecture 
and the ability to determine the dimension of the micelle, resulting in a multitude of 
possible applications. They can be used, for example, as catalysts or as hosts for 
organic low molecular weight guest molecules. [112] In addition, they are often able to 
stabilize metal nanoparticles. Characteristic of unimolecular micelles is, that the 
amphiphilic molecular parts of the aggregate are covalently linked together by a central 
molecule. This covalently linked core-shell architecture with a defined, adjustable 
microenvironment in the core, that is different from the adjustable microenvironment of 
the shell, may allow targeted encapsulation of guest molecules based on 
supramolecular interactions. [ 113 ] This leads to new applications in the field of 
encapsulation and transport of guest molecules, as templates for the synthesis of 
catalytically active metal nanoparticles or as interesting materials for the development 
of sensors.[ 114 ] However, most commonly these polymers are used in targeted 
pharmacotherapy (targeted drug delivery).[115] Compared to classic micelles, which are 
based on the association of low molecular weight amphiphilic molecules, unimolecular 
micelles are characterized by increased stability towards temperature, pH, solvents 
and other physical and chemical influences due to the covalent linkages. Due to this 
linkage in unimolecular micelles, there is no dynamic equilibrium between the 
individual amphiphilic molecules and the micelle. Individual parts of the molecule 
cannot leave the union of the unimolecular micelle, which makes them independent of 
the complex self-aggregation processes of classical micelles.[116, 117] 
These core-shell structures of unimolecular micelles can be constructed from different 
polymer architectures (Figure 2). 
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Figure 2: Various polymer architectures which can act as unimolecular micelles with 
hydrophobic chains (black) and hydrophilic chains (blue).[118] 
 
Polymers with hyperbranched or cross-linked hydrophobic chains attached to 
hydrophilic chains show amphiphilic properties and behave like unimolecular 
micelles.[119-121] For the construction of such architectures, a linear hydrophilic polymer 
is first synthesized. Subsequently, a di- or multifunctional and hydrophobic monomer 
(e.g. a divinyl compound) is added to form a crosslinked core. The control over this 
reaction is usually difficult, whereby the core dimensions are difficult to adjust and 
usually inconsistent. Moreover, it is impossible to predict the exact number of 
hydrophilic arms on the core. As a consequence, polydisperse particles are often 
formed.[122] 
Furthermore, graft copolymers with a hydrophobic backbone, which carries hydrophilic 
side chains can also adopt a core-shell conformation. An advantage of this type of 
macromolecule is, that different micellar shapes can be achieved, depending on the 
chain stiffness of the backbone. For example, a chain-rigid polymer backbone can form 
cylindrical micellar shapes, while flexible backbones are expected to form spherical 
micelles.[123] 
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Dendrimers bearing polar groups can also form unimolecular micelles.[124, 125] They are 
very well-defined in their dendritic structure, but require multistep organic 
syntheses.[126-130] 
The best control over the dimension of the unimolecular micelle is achieved through 
the synthesis of star-shaped block copolymers with their covalently linked and 
hydrophobic core bound to a hydrophilic shell.[ 131 , 132 ] They often show similar 
properties and applications, but are much easier to synthesize. The advantage of such 
star-shaped block copolymers is, that the number of arms can be precisely adjusted 
by the number of initiation groups. In addition, the lengths of the hydrophobic and 
hydrophilic blocks can also be precisely adjusted by the concentration ratio between 
monomer and initiator. This allows the adjustment of the solution properties and the 
dimensions of the micelle. The synthesis of such star-shaped block copolymers has 
been realized in a variety of ways and it has been shown, that their properties and 
applications often resemble those of dendrimers or hyperbranched polymers.[133, 134] 
Recently, polypeptide PEG miktoarm star-shaped polymers with a fluorescently 
labeled core molecule have been prepared by RAFT (reversible addition-fragmentation 
chain transfer) and click chemistry.[135] In addition to a low cytotoxicity, these polymers 
could complex and transport siRNA (small interfering ribonucleic acid). Furthermore, 
ABC miktoarm star-shaped polymers with poly(3-hexylthiophene), polystyrene and 
poly(2-vinylpyridine) segments and low dispersities (Đ < 1.05) were prepared by an 
efficient combination of polymer conjugation and living anionic polymerization.[ 136 ] 
Whittaker et al. also reported a simple and highly efficient method based on iterative 
Cu(0)-mediated controlled radical polymerization for the synthesis of highly-defined 
multiblock star-shaped copolymers.[137] Thus, 5-armed star-shaped polymers with up 
to five different polymer blocks in each arm could be obtained. Sequential ATRP has 
also been used to synthesize 21-arm star-shaped polymers based on initiator-
functionalized cyclodextrin.[ 138] The arms were made of poly(tert-butyl acrylate)-b-
polystyrene. After hydrolysis of the tert-butyl esters, amphiphilic polymers were 
obtained and their unimolecular micellar behavior was confirmed by DLS (Dynamic 
light scattering), TEM (Transmission electron microscopy) and AFM (Atomic force 
microscopy). 
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2.5 Drug delivery systems 
 
Drug delivery systems have become of great interest in recent years. The efficient 
transport of a drug not only improves its efficiency, but also its patient tolerance. This 
is especially the case when an active ingredient does not reach its target tissue, or only 
to a small extent. Many drugs also require frequent use and often have side effects of 
varying degrees. In addition, drug delivery also simplifies the handling of a drug and 
an improved compliance with the dosing rules can be achieved. As many highly potent 
drugs already exist, the interest has focused on optimizing drug effects via new drug 
delivery systems.[139]  
 
 
Figure 3: The route of the drug from its dosage form to its elimination from the 
organism.[140] 
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Before discussing the possible drug delivery systems, the route of the drug from its 
dosage form to its elimination from the organism will be explained (Figure 3). 
A drug is a substance, which is responsible for the pharmacological effect. This 
substance is converted to its dosage form and consists the active pharmaceutical 
ingredient as well as additives and excipients, which should not show any 
pharmacological effects of their own (for example pills or drug delivery systems). The 
subsequent liberation of the drug from the dosage form is characterized by solubility 
and dissolution rate and is influenced by local temperature and blood flow. This is 
followed by the absorption of the drug from the body surface or from inside the body 
to the bloodstream or lymphatic system. The resorption of the drug is a requirement 
for its effect. The drug has to overcome the skin, the mucous membrane or other 
barriers. The amount of drug, which is resorbed from the dosage form per time, is 
called bioavailability. The following distribution is the way in which a drug is distributed 
to the body tissue or organs. The most important requirement for the distribution of a 
drug in the organism is a corresponding blood supply. Drugs can also be effective in 
the blood itself. The final elimination describes all processes that stop the effect of the 
drug. This can be done by a chemical transformation of the drug or by elimination 
through various organs (metabolism). Most drugs are eliminated via the kidneys, the 
intestine, the lungs or the skin.[140] 
The drug delivery system should, in the best case, deliver the drug at a constant rate. 
This continuous resorption makes it possible to equalize the liberation of the drug to 
its elimination, which should create an equilibrium. In comparison to conventional 
dosage forms, significantly lower amounts of substance are required. These reduced 
amounts result in a reduction of undesired side effects and an increased safety of the 
medication therapy. Conventional dosage forms show a short effective duration, which 
leads to a relatively high application frequency and a fluctuation of the concentrations 
in the blood and in the tissue. High concentrations alternate with low concentrations, 
so that an optimal therapeutic concentration is achieved only for a limited time. These 
concentration variations and the limited effective duration of conventional dosage 
forms have led to the concept and realization of (controlled) drug delivery systems. 
The majority of newly developed drug delivery systems include polymers, which have 
to demonstrate the following requirements:[141] 
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• simple application 
• low price and easy synthesis 
• low polydispersity 
• good solubility 
• biocompatibility 
• biodegradability 
• reproducible and constant liberation rate 
• safety against overdoses 
• less side effects due to lower dosage 
 
By using polymeric drug delivery systems, not only the effect of the drug, but also the 
effect of the dosage form on the recipient tissue must be considered. In addition, it 
must be ensured, that the properties of the polymers do not change adversely during 
exposure in the biological environment. For degradable polymers, the degradation 
products should not be toxic or carcinogenic. Furthermore, they should be excreted as 
quickly as possible with the least possible accumulation in the tissue. There are several 
drug delivery systems, which have advantages and disadvantages depending on the 
application. 
 
2.5.1 Membrane systems 
 
In membrane systems, the drug, encapsulated in one or more membranes, is applied 
to the body and passes through the membranes into the organism via diffusion or 
osmosis. The membranes are usually semipermeable. Microporous membranes allow, 
depending on pore size, diffusion of higher molecular weight drugs. In microporous, 
degradable membranes, the operational removal of the membrane system after 
consumption of the drug is not necessary. Such systems degrade in the body by 
hydrolytic or enzymatic degradation.[142] When the membrane system comes in contact 
with the body fluid, water diffuses through the solid membrane into the system. As a 
result, the hydrostatic pressure increases within the membrane, which allows the 
constant release of the drugs. The diffusion characteristics of polymers can be 
influenced by several factors, which is of great importance for membrane systems 
which exhibit diffusion-controlled drug release (Table 1).[ 143 ] For polymers having 
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relatively stiff backbones, such as polystyrene, diffusion decreased due to the 
increased mobility of the chain segments compared to polymers having flexible 
backbones, such as polyethylene. For membrane systems polysiloxanes, hydrogels 
and polyvinyl acetate are frequently used. These polymers are relatively inert to drugs 
and only degrade slowly in the body.[144] 
 
Table 1: Influencing factors on the diffusion coefficient of polymers.[143] 
influencing factors of the polymer 
influence on 
diffusion coefficient 
molecular weight ↑ ↓ 
degree of cross-linking ↑ ↓ 
stiffness of the backbone ↑ ↓ 
interaction between molecules ↑ ↓ 
degree of crystallization ↑ ↓ 
plasticizer content ↑ ↑ 
filler content ↑ ↑ 
 
 
2.5.2 Matrix systems 
 
In matrix systems, the drug is dissolved or dispersed in the polymer matrix. For such 
drug delivery systems, microporous or biodegradable matrix systems are used. In 
degradable therapeutic systems, where the drug is distributed or chemically bound in 
the degradable polymer matrix, the rate of release depends on the rate of degradation 
of the polymer. Depending on the material, the degradation occurs hydrolytically or 
enzymatically. For such systems, water-soluble polymers and hydrolytically or 
enzymatically degradable polymers are used. Examples of these are polylactides, 
polyglycolides, poly (ε-caprolactone) or poly (β-hydroxybutyric acid). In the degradable 
systems, mixtures of the polymer and the drug are processed simultaneously. At high 
processing temperatures, such as in the extrusion process, the drug should not show 
thermally induced chemical changes. With limited temperature stability of the drug, an 
alternative processing method (processing from the solution) must be chosen.[144] 
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2.5.3 Carrier systems 
 
In drug carrier systems, the drug is chemically bound to the side chains of a degradable 
or biologically inert backbone.[145] Advantages of those systems are a higher specificity 
due to a higher availability of the drug, a longer effective duration and increased 
therapeutic effect. In addition, carrier systems generally have a very high drug content 
of up to 80 weight percent.[146] The polymer carrier must be hydrophilic to ensure 
solubility in water and should have the necessary functional groups for covalent 
attachment of the drug. The concept of covalent attachment of a biodegradable spacer, 
which can be cleaved by specific enzymatic or hydrolytic reaction, has been proposed 
to make the drug effective at a specific release rate at a specific location.[147] In order 
to allow a specific localization, it has also been proposed, that in addition a specific 
functional group (targeting residue) is bound to the polymer in order to achieve a cell-
specific uptake (Figure 4). Among the polymers investigated so far, dextran, 
polyethylene glycol, N-(2-hydroxypropyl)methacrylamide (HPMA)-copolymers and 
polyaspartic acid have been established as non-toxic polymers for the use as carrier 
materials.[148] 
 
 
Figure 4: Structure of a water-soluble polymeric carrier material for drug delivery 
systems.[147, 148] 
 
2.5.4 Micelles and liposomes 
 
Classical micelles in aqueous solutions formed by self-assembly of amphiphilic block 
copolymers (5-50 nm) or unimolecular micelles (see chapter 2.4) became very 
important in the field of drug delivery applications. The drugs are physically 
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encapsulated in the core of the micelles and transported using concentrations, which 
would normally not be possible due to the limited water solubility of some drugs. Due 
to the hydrophilic shells, the micelles can form hydrogen bonds with the aqueous 
environment to protect itself against hydrolysis and enzymatic degradation. The fact, 
that the molecular weight and block length and in the case of unimolecular micelles the 
number of arms can be easily changed, allows control of the morphology and size of 
the micelles. This allows the setting of certain properties for the desired drug. 
Furthermore, block copolymers can be functionalized with cross linkable molecules to 
increase the stability of the classical micelles.[149, 150] 
Liposomes have a membrane shell of a bilayer of molecules that have both a non-polar 
and a polar part. Therefore, water-soluble drugs were encapsulated inside the 
aggregation of the hydrophobic ends and fat-soluble drugs were encapsulated into the 
hydrophilic layer. Synthetic liposomes are mostly stable in the organism and show a 
low toxicity.[150-153] 
In both cases the micelles or the liposomes are affiliated from phagocytic cells and 
degraded to release the drug.[150] 
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3. AIM 
 
The aim of this work was the establishment of a straightforward and scalable synthesis 
of unimolecular micelles based on amphiphilic star-shaped block copolymers with 
adjustable microenvironment in the core and a water-soluble shell. For this purpose, 
the Passerini-3CR reaction, using an AB-type monomer and multifunctional core 
molecules acting as ICTA, should be used, to obtain water-soluble core-shell 
architectures with different numbers of arms and adjustable degree of polymerization. 
A synthesized library of amphiphilic star-shaped block copolymers with selective 
structural variation, polarity of the core, shell architecture and degree of polymerization 
should be investigated for their unimolecular micellar behavior and their encapsulation 
and transport behavior for a better understanding of structure-property relationships 
and thus the design of new host-guest polymers. Furthermore, the biocompatibility and 
the potential application as drug delivery systems of these polymers should be 
confirmed. 
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4. RESULTS AND DISCUSSION 
 
4.1 Controlling molecular weight and polymer architecture via the 
Passerini-3CR 
 
This chapter and the associated sections in the Experimental Part were published 
previously: 
S. Oelmann, S. C. Solleder, and M. A. R. Meier, Polym. Chem., 2016, 7, 1857. 
Copyright © 2016, permission from the Royal Society of Chemistry. 
 
 
 
Abstract 
A new approach to control the molecular weight and polymer architecture using the 
Passerini three-component step-growth polymerization is described. Starting from an 
AB-type monomer, linear homopolymers, diblock copolymers, as well as star-shaped 
polymers were synthesized in an efficient manner. By varying the ratio of the AB-type 
monomer and a suitable ICTA, different polymer architectures with specific molecular 
weights and high end-group fidelity were obtained. 
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Introduction 
In order to obtain better control over the material properties of polymers, it is essential 
to synthesize polymers with well-defined structures.[ 154 ] Usually, living/controlled 
polymerization techniques, such as reversible addition-fragmentation chain transfer 
(RAFT) or atom transfer radical polymerization (ATRP), which are the most extensively 
studied controlled radical polymerization techniques, or anionic polymerization are 
used to prepare various well-defined macromolecular architectures.[155] However, well-
defined polymers were also synthesized via polycondensation reactions by using 
monomers, which react selectively with the polymer chain ends.[156-158] For instance, 
our group synthesized defined macromolecular architectures using head-to-tail acyclic 
diene metathesis (ADMET) polymerization.[ 159 , 160 ] This synthesis procedure was 
accomplished by taking advantage of the different reactivities of terminal double bonds 
and acrylates in olefin metathesis reactions.[161] 
Recently, multicomponent reactions (MCRs) have been introduced to the field of 
polymer science as straightforward polymerization technique with a step-growth 
character.[162] This type of reaction is performed with more than two starting materials 
in one-pot and leads to functional materials in a straightforward fashion. In polymer 
chemistry, isocyanide-based multicomponent reactions (IMCRs), such as the 
Passerini-3CR, are often used.[163, 164] For instance, by using bifunctional components, 
a polymerization process is induced and substituted polyesters, polyamides and 
poly(ester amide)s are obtained.[ 165 - 167 ] Furthermore, with AB-type bifunctional 
monomers, it is possible to perform the reaction with only two components, which leads 
to an easier and more efficient polymerization process.[168, 169] It is also possible to 
synthesize multi-block copolymers with sequence-ordered side groups.[ 170 ]  
Moreover, several applications of metal-catalyzed MCRs are described in polymer 
chemistry.[171, 172] 
 
4.1.1 Synthesis of linear homo- and block copolymers 
 
This section focusses on the synthesis of well-defined polymer architectures employing 
the Passerini-3CR as polymerization technique. The approach relies on the use of a 
monocarboxylic acid as an ICTA in combination with bifunctional monomer 3 and an 
isocyanide to achieve control over the molecular weight. The thus resulting carboxylic 
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acid end-group subsequently allows the synthesis of block copolymers. Moreover, the 
use of a tricarboxylic acid as core unit should result in the formation of star-shaped 
homo- and copolymers. Thus, an AB-type monomer 3, containing a carboxylic acid 
and an aldehyde unit was prepared by a thiol-ene reaction of 10-undecenal 1 and 3-
mercaptopropionic acid 2 (Scheme 23).[168] 
 
 
Scheme 23: Synthesis of AB-type monomer 3 via thiol-ene reaction. 
 
The Passerini polymerization of monomer 3 was then performed in dichloromethane 
(DCM) at room temperature using four different isocyanides 5-8 with a ratio of 
monomer 3 : isocyanide 5-8 : 10-undecenoic acid 4 of 20:100:1. 10-Undecenoic acid  4 
served as ICTA (Scheme 24).  
 
 
Scheme 24: Passerini-3CR using different isocyanides 5-8. 
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Molecular weights of the obtained polymers were measured by SEC and additionally 
calculated from 1H NMR data (see associated sections in the Experimental Part). If this 
process proceeds as anticipated, monomer 3 as well as the formed oligomers of 3 and 
the respective isocyanide would add irreversibly to 4 (and later on growing polymer 
chains) until all monomer is consumed and the molecular weight would be 
predetermined by the ratio of [3]:[4], comparable to the monomer : initiator ratio in 
controlled/living polymerizations. The calculated molecular weights were calculated 
with following formula: 
 
 = Monomer	 + Isocyanide ∗ n + ITCA	 
 
Representative example with P1: 
 
 = 274.42
g
mol + 83.13
g
mol% ∗ 20 + 184,27
g
mol = 7,335
g
mol 
 
Indeed, for all investigated isocyanides 5-8, the expected molecular weights 
corresponded well to the actual values determined by 1H NMR integration of the end 
group signal and the signals of the repeating units (Table 2).  
 
Table 2: Molecular weights of polyesters P1-P4 synthesized with different 
isocyanides 5-8 (ratio monomer 3 : isocyanide 5-8 : 10-undecenoic acid 4 of 20:100:1). 
polymer 
 
Mn calc. 
[g/mol] 
Mn NMR 
[g/mol] 
Mn SEC 
[g/mol] 
Ð 
Mw/Mn 
Tg 
[°C] 
P1 7,335 7,377 12,000 1.51 5 
P2 7,616 7,950 11,800 1.51 -11 
P3 7,856 8,884 12,000 1.67 3 
P4 8,016 7,052 11,000 1.46 1 
 
SEC analysis revealed higher molecular weights than expected, which is due to the 
different hydrodynamic volumes compared to the linear PMMA calibration standards. 
The thermal properties of the polyesters were determined by DSC, which revealed an 
amorphous behavior with glass transitions (Tg) ranging from -11 °C to 5 °C, depending 
on the isocyanide. 
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Delighted by these results, the polymerization behavior was further investigated by a 
step-wise addition of monomer 3 in portions of five equivalents. After each batch 
addition of fresh monomer, the reaction was allowed to proceed until there was no 
more change in molecular weight by SEC (Figure 5) and longer times to reach a 
constant molecular weight were required after each addition. 
 
 
Figure 5: SEC chromatogram showing the growth of polyester P1 during the addition 
of 5 equivalents of monomer 3 after specific time periods measured from reaction 
mixture; (a = first (0 h), b = second (2 h), c = third (4.5 h), d = fourth addition (7.5h), 
e  = 24 h). 
 
Most importantly, it was clearly shown by this experiment, that the polymer chain grows 
until all monomer is consumed and that the polymerization can be continued, i.e. the 
chain extended, by simply adding additional amounts of monomer 3. After two hours a 
1H NMR spectra of the crude reaction mixture was measured to see if there was a full 
conversion of AB-type monomer 3. Figure 6 confirmed this assumption, since no 
aldehyde signal could be observed. 
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Figure 6: Comparison of 1H NMR spectra of AB-type monomer 3 (above) and P1 
(below) after 2 hours with 5.00 equivalents of monomer 3 and without precipitation. 
 
To further demonstrate the control over the molecular weight using this method, 
different ratios of AB-type monomer 3 and ICTA 4 (10:1 to 40:1) were investigated 
(Scheme 25). 
 
 
Scheme 25: Passerini-3CR using different ratios of AB-type monomer 3 and ICTA 4 
(10:1 to 40:1). 
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It could be shown that the molecular weights of the resulting polymers calculated from 
1H NMR data were in good agreement with the expected molecular weights (Table 3). 
Furthermore, the SEC results show an increase of the molecular weight using higher 
ratios of AB-type monomer 3 and ICTA 4 by a shift of the curve to lower retention times 
(Figure 7).  
 
Table 3: Molecular weights of polyesters P1 and P5-P7 obtained by using different 
ratios of monomer 3 and ICTA 4 (determined by 1H NMR and SEC). 
polymer 
ratio 
[3]:[4] 
Mn calc. 
[g/mol] 
Mn NMR 
[g/mol] 
Mn 
SEC 
[g/mol] 
Ð 
Mw/Mn 
P5 10:1 3,760 4,146 9,100 1.60 
P1 20:1 7,335 7,377 12,000 1.51 
P6 30:1 10,911 10,997 14,200 1.40 
P7 40:1 14,486 14,515 15,700 1.37 
 
 
Figure 7: SEC results of polymerizations with varying ratios of AB-type monomer 3 
and 10-undecenoic acid 4 (P5 = 10:1, P1 = 20:1, P6 = 30:1, P7 = 40:1). 
 
Using a ratio of [3]:[4] of 40:1, a further addition of isocyanide 5 after 24 hours was 
necessary to obtain full conversion. A reason could be the increasing viscosity of the 
reaction mixture upon reaching higher molecular weights. By diluting the mixture with 
additional isocyanide 5, viscosity decreased while reactivity increased, leading to full 
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conversion. Each linear homopolymer P1-P7 was additionally characterized via mass 
spectroscopy (see associated sections in the Experimental Part). Figure 8 is showing 
the representative mass spectra of P1 with the expected number of repeating units n 
as well as the expected theoretical masses, respectively. Unfortunately, proper 
ionization of P4 was not possible. 
 
 
Figure 8: Mass spectra of homopolymer P1 with n repeating units and a calculated 
mass of 357.234 g/mol per repeating unit (a = retention time of 13.14 min, b = retention 
time of 11.84-14.05 min, c = calculated isotope pattern, d = experimental isotope 
pattern at a retention time of 13.14 min). 
 
Starting from homopolymer P1, which reacts as macro ICTA, a chain extension by a 
second Passerini polymerization was performed with benzyl isocyanide 8 under the 
same reaction conditions yielding diblock copolymers P8 and P9 by the use of different 
ratios (monomer 3 : homopolymer P1, 20:1 (P8) and 10:1 (P9)) (Scheme 26). 
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Scheme 26: Passerini-3CR to form block copolymers P8 and P9 using different ratios 
of AB-type monomer 3 and macro ICTA P1 for the second block containing benzyl side 
groups. 
 
1H NMR analysis of the resulting polymers P8 and P9 showed an excellent correlation 
of the double bond end group signals and the signals of the two different blocks. 
Symmetric molecular weight distribution, showing the presence of a unique block 
copolymer and full monomer conversion were observed by SEC analysis (Figure 9). 
The molecular weights calculated from 1H NMR data fit to the expected molecular 
weights of P8 (15,300 g/mol) and P9 (11,300 g/mol), respectively. 
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Figure 9: SEC results of diblock copolymer P9 synthesized from homopolymer P1 in 
ratios of the two different blocks of 20:10 (tert-butyl side group : benzyl side group). 
 
4.1.2 Synthesis of three-armed star-shaped homo- and block 
copolymers 
 
To extend this study, ICTA 4 was replaced by a trifunctional core unit 9, which should 
result in the formation of a star-shaped homopolymer and subsequently in a star-
shaped copolymer. The Passerini polymerization was performed with tert-butyl 
isocyanide 5 and AB-type monomer 3 with a ratio of 
monomer 3 : isocyanide 5 : trimesic acid 9 of 60:300:1 (Scheme 27).  
 
 
Scheme 27: Synthesis of star-shaped homopolymer P10 using a trifunctional ICTA 9. 
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Subsequent SEC analysis revealed lower molecular weights than the theoretical 
calculation, which is typical for star-shaped polymers. 1H NMR analysis of star-shaped 
homopolymer P10 indicated complete conversion of the ICTA by a slight shift of the 
aromatic protons a of the core unit compared to the protons of trimesic acid 9 (see 
associated sections in the Experimental Part). With a ratio of 60:1 (AB-type monomer 
3 : core 9), full monomer conversion was detected by 1H NMR. The ratio of the protons 
a of the core, to the protons b and c of the arms, confirmed this assumption. The 
resulting star-shaped polyester P10 was chain-extended by a further Passerini reaction 
with benzyl isocyanide 8 under the same reaction conditions, leading to star-shaped 
block-copolymer P11 (Scheme 28).  
 
 
Scheme 28: Passerini-3CR to obtain star-shaped block copolymer P11 using benzyl 
isocyanide 8. 
 
While the first block still exhibits 20 monomer units, the second block was synthesized 
with a ratio of 10:1 (AB-type monomer 3 : homopolymer P10). This leads to an overall 
ratio of the two blocks of 20:10, which was confirmed by the integrated signal of 
protons b-c and d-g (see associated sections in the Experimental Part). The growth of 
the second block can be seen again in the SEC results of star-shaped homopolymer 
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P10 and star-shaped block copolymer P11 by a shift of the curves to lower retention 
times as well as the presence of a unique star-shaped block copolymer and full 
monomer conversion (Figure 10). 
 
Figure 10: SEC results of star-shaped homopolymer P10 and star-shaped 
copolymer P11. 
 
In order to investigate the reactivity and end-group fidelity of the carboxylic acid end 
groups, P10 was activated with carbonyldiimidazole 10 (CDI).[173] The reaction was 
carried out in DCM at room temperature for one day to obtain P12 (Scheme 29).  
The modification of the end group with CDI 10 was verified by 1H NMR analysis (see 
associated sections in the Experimental Part). The ratio of the protons e, d and f to 
protons a of the core unit indicate full conversion of the end groups. This proves that 
the carboxylic acid chain ends are still reactive and further modifications can be carried 
out. 
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Scheme 29: Activation of the end group of star-shaped homopolymer P10 with CDI 10. 
 
Conclusion 
In summary, a new approach for the synthesis of polymers with a defined 
macromolecular architecture by a non-classic step-growth polymerization technique 
was demonstrated. An AB-type monomer containing an aldehyde and a carboxylic acid 
moiety was synthesized and polymerized in a Passerini reaction with four different 
isocyanides and an ICTA. With this simple polyaddition process, α-amide substituted 
polyesters with controlled molecular weights were synthesized. Furthermore, diblock 
copolymers, star-shaped homo- and copolymers could be synthesized in this way. By 
modifying the carboxylic acid end group, further reactions can be performed on the 
polymer to tune the properties of these materials. The described strategy offers a 
variety of straightforward new possibilities for the design of defined polymer 
architectures.  
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4.2. Synthesis and investigation of unimolecular micelles via the 
Passerini-3CR 
 
This chapter and the associated sections in the Experimental Part were published 
previously: 
S. Oelmann, M. A. R. Meier, RSC Adv., 2017, 7, 45195. Copyright © 2017, permission 
from the Royal Society of Chemistry. 
 
 
 
Abstract 
A series of new amphiphilic star-shaped block copolymers with hydrophobic cores and 
hydrophilic shells was synthesized, using the Passerini three-component step-growth 
polymerization (Passerini-3CP). The degree of polymerization of the Passerini 
hydrophobic cores (20, 10 and 5 repeating units) was controlled and the chain ends 
were quantitatively functionalized with different sized PEG-aldehydes and/or PEG-
isocyanides via another Passerini reaction. The encapsulation and phase transfer 
properties of the star-shaped block copolymers were followed visually and by UV/VIS-
spectroscopy, using Orange II and Para Red dyes as guest molecules. The 
investigated polymers showed a unimolecular micellar behavior, as confirmed by 
dynamic light scattering (DLS) and the already mentioned encapsulation experiments. 
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Introduction 
Unimolecular micelles show interesting properties for a wide range of applications, 
including catalysis or the encapsulation of low molecular weight organic guest 
molecules.[174, 175] The first in literature described systems behaving like unimolecular 
micelles were based on dendrimers.[176-178] However, dendrimers often require difficult 
multi-step organic syntheses. Polymer-based systems with core-shell architecture 
often show similar properties but are easier to synthesize and thus constitute suitable 
alternatives. For example, amphiphilic star-shaped polymers having a defined number 
of arms and, accordingly, end groups, can be used in different applications, due to their 
behavior as unimolecular micelles.[179-183] Most commonly, these amphiphilic star-
shaped polymers are synthesized by ATRP or other controlled/living polymerization 
techniques (e.g. nitroxide-mediated radical polymerization (NMP), RAFT or anionic 
polymerization).[ 184 - 186 ] Additionally, ring-opening polymerization of lactides and 
lactones is often used to synthesize star-shaped polymers.[187] In the previous chapter, 
it was demonstrated that star-shaped block copolymers can be synthesized via the- 
Passerini-3CR in a step-growth process.[188, 189]  
 
4.2.1 Synthesis of three-armed star-shaped homopolymers 
 
Following the work of the previous study, this chapter describes the synthesis of well-
defined amphiphilic star-shaped block copolymers using the Passerini-3CR and the 
subsequent encapsulation of two different dyes. This approach is based on the use of 
a trifunctional carboxylic acid as an ICTA in combination with the AB-type monomer 3. 
It was recently shown, that by using an ICTA, an AB-type monomer (combination of 
aldehyde and carboxylic acid), and an excess of isocyanide, the molecular weights 
obtained in a Passerini-3CR are determined by the ratio of monomer : ICTA (in analogy 
to the monomer : initiator ratio in living/controlled polymerizations). To investigate 
potential applications of these star-shaped homopolymers, it was focused on their 
functionalization with PEG chains, to produce amphiphilic polymers and to study their 
encapsulation behavior. The synthesis of AB-type monomer 3 and star-shaped 
homopolymer P10 has been described in a previous publication and in the previous 
section.[188] Additionally, two star-shaped homopolymers with shorter arm lengths (P13 
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and P14, 10 and 5 repeating units) were synthesized using ratios of 30:1 and 15:1 of 
[3]:[9] (10:1 and 5:1 per arm respectively) (Scheme 30). 
 
 
Scheme 30: Passerini-3CR to obtain star-shaped homopolymers P10, P13 and P14 
with different number of repeating units.[188] 
 
The molecular weights (Mn) of the star-shaped polymers, determined by 1H NMR end 
group integration, were consistent with the expected molecular weights (see 
associated sections in the Experimental Part) and confirmed a degree of 
polymerization of 10 and 5, respectively (Table 4).  
 
Table 4: Molecular weights of polyesters P10, P13 and P14 synthesized with different 
ratios of AB-type monomer 3 and trimesic acid 9. 
polymer 
ratio 
[3]:[9] 
per arm 
Mn 
calc. 
[g/mol] 
Mn 
NMR 
[g/mol] 
Mn 
SEC 
[g/mol] 
Ð 
Mw/Mn 
P10 20:1 21,663 22,031 13,500 1.40 
P13 10:1 10,937 10,829 10,200 1.23 
P14 5:1 5,573 5,859 6,500 1.40 
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The observed molecular weight distribution (Figure 11) was symmetric and confirmed 
full monomer conversion. The obtained dispersities (1.23-1.40) are lower than for a 
classic step-growth polymerization, indicating the presence of both step-growth and 
chain-growth mechanisms in this system, as expected. 
 
Figure 11: SEC results of star-shaped homopolymers P10, P13 and P14 with varying 
ratio of AB-type monomer 3 and trimesic acid 9 (P10 = 20:1, P13 = 10:1, P14 = 5:1; 
per arm). 
 
4.2.2 Functionalization with PEG-isocyanides and PEG-aldehydes 
 
The star-shaped homopolymers P13 and P14 were subsequently functionalized with a 
water-soluble PEG-based shell to obtain water-soluble star-shaped block copolymers 
with the goal to achieve unimolecular micellar behavior. Two strategies based on the 
Passerini-3CR were used to produce linear or branched star-shaped block 
copolymers. For this purpose, the COOH end groups of the star-shaped polymers were 
reacted with a PEG aldehyde and an isocyanide or with a PEG aldehyde and a PEG 
isocyanide in a Passerini-3CR to form a water-soluble shell with either one or two PEG 
chains per arm. In first tests, P13 was converted with a commercially available PEG-
aldehyde 12 (2,000 g/mol) in a ratio of 1:1 (per arm) and an excess of tert-butyl 
isocyanide 5, benzyl isocyanide 8 or tert-butyl-2-isocyanoacetate 11 (Scheme 31). 
After precipitation in diethyl ether, the functionalized polymers P15, P16 and P17 were 
obtained in good yields.  
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Scheme 31: Functionalization of P13 and P14 with different isocyanides 5, 8, 11 and 
PEG aldehyde 12 (2,000 g/mol) to obtain block copolymers P15, P16, P17 and P18. 
 
 
Figure 12: SEC results of the functionalization of P13 using a PEG aldehyde 
(2,000 g/mol) and different isocyanides. 
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Complete conversion of the end groups was confirmed by 1H NMR (see associated 
sections in the Experimental Part) and SEC measurements (Figure 12).  
Although the polymer end groups were fully functionalized, the water solubility of the 
polymers P15, P16 and P17 were rather poor and insufficient to obtain unimolecular 
micelles soluble in water. Thus, the smaller cores were used (P13 and P14) and it was 
not continued with the investigations of P10. Therefore, P18 was synthesized using 
the smaller hydrophobic core P14 with tert-butyl isocyanide 5 and PEG aldehyde 12 to 
increase the hydrophilic fraction of the copolymers (Scheme 31). 
Moreover, in order to investigate the influence of the molecular weight of the PEG 
chains as well as the effect of branching at the core-shell connection on the 
aggregation and encapsulation behavior of the star-shaped block copolymers in water, 
lower molecular weight functionalized PEGs were used. For the preparation of PEG 
isocyanide 21, an end-group modification of methoxy PEG 20 via a transesterification 
with isocyanide 19 was used. The three-step synthesis of isocyanide 19 starting from 
amine 13 is known in literature.[190] First, methyl ester 15 is obtained and afterwards 
formamide 17 is formed, which is finally converted to isocyanide 19 (Scheme 32). 
 
 
Scheme 32: Synthesis route of PEG isocyanide 21.[190] 
 
PEG aldehyde 23 (950 g/mol) was synthesized by end group modification of 
commercially available PEG thiol 22 via a thiol-ene reaction with 10-undecenal 1 
(Scheme 33). 
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Scheme 33: Synthesis of PEG aldehyde 23 via thiol-ene reaction. 
 
Having the functionalized PEGs in hand, the star-shaped block copolymers P19, P20 
and P21 were synthesized via the Passerini-3CR, using tert-butyl isocyanide 5 and 
PEG aldehyde 23, or PEG isocyanide 21 and PEG aldehyde 23 to obtain polymers 
with either one or two PEGs (950 g/mol) and either 5 or 10 repeating units of the core 
(Scheme 34). 
Thus, a small library of four different amphiphilic star-shaped block copolymers was 
produced and further investigated, allowing the correlation of the different polymer 
architecture to the performance as unimolecular micelles. The full conversion of the 
end groups was determined by 1H NMR measurements (see associated sections in 
the Experimental Part). Due to an increased hydrophilic ratio, polymers P18, P19, P20 
and P21 showed improved water solubility. All following evaluations were performed 
only on these four water soluble polymers. 
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Scheme 34: Functionalization of P14 with tert-butyl isocyanides 5 and PEG 
aldehyde 22 (950 g/mol) to obtain star-shaped block copolymer P19 and additional 
functionalization of P13 and P14 with PEG isocyanide 21 and PEG aldehyde 22 
(950 g/mol) to obtain star-shaped block copolymers P20 and P21. 
 
Due to the differences in solubility of the two blocks in water, the formation of 
aggregates might be expected, contradicting a unimolecular micellar behavior. 
Nevertheless, dynamic light scattering (DLS) measurements confirmed unimolecularity 
for the four star-shaped block copolymers in a concentration range from 0.1 mg/mL 
and 1.0 mg/mL (see associated sections in the Experimental Part). The measurements 
were carried out in water and dichloromethane (DCM). Two different preparation 
protocols, typical for the preparation of micellar solutions, were used for the analysis 
in water.[191] On the one hand, the sample was directly dissolved in water (without 
acetone: woA) and on the other hand, the sample was dissolved in 2-3 drops of 
acetone and then water was added dropwise (with acetone: wA). The values of all four 
polymers measured woA were slightly higher (13.5-21.0 nm) compared to the values 
wA (8.7-15.7 nm), which may indicate some aggregation in water. To confirm this and 
possibly break these aggregates, P18 wA and woA was ultrasonicated for 5 minutes 
each (P18 showed the largest size difference for the two preparation modes). 
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Afterwards, all samples showed the same value (value of the sample wA: Figure 13), 
indeed indicating that small aggregates were present for the woA samples and also 
indicating that the wA samples indeed represent unimers that cannot be further 
dissociated. The values measured in DCM were slightly lower (4.2-6.5 nm), which can 
be attributed to a different swelling behavior of these macromolecules in an aqueous 
solution. 
 
 
Figure 13: DLS results of functionalized star-shaped polymer P18: comparison of 
1 mg/mL P18 with and without acetone after and before ultrasonication (US). 
 
4.2.3 Encapsulation and phase transfer studies of various dyes 
 
Most interestingly, the guest encapsulation of the star-shaped block copolymers and a 
phase transfer phenomenon was observed and could be visualized in the following 
tests, also unambiguously confirming unimolecularity. Encapsulation behavior was 
obtained for all four tested star-shaped block copolymers P18, P19, P20 and P21 (see 
  4. Results and Discussion 
 
 
61 
associated sections in the Experimental Part), but the best results were received for 
polymer P20 (Figure 14). First, amphiphilic star-shaped block copolymers were added 
to the water insoluble dye Para Red, rendering it water-soluble due to encapsulation. 
Polymers with shorter hydrophobic cores and higher hydrophilic parts were better 
soluble in water and exhibited the best encapsulation behavior of the dye (Figure 
14, left). 
In a second test, the water-soluble dye Orange II was added to a two-phase 
water/DCM system (Figure 14, right). After addition of the amphiphilic star-shaped 
block copolymer and shaking for a few seconds, most of the dye was transferred to the 
DCM phase. The color change from orange to yellow of Orange II is due to a change 
of the microenvironment of the dye and confirms that the polymers can encapsulate 
and phase transfer the investigated guest molecule. This result is a clear proof of the 
unimolecular behavior of the polymer, since a self-assembled micelle would dissociate 
in DCM, not being able to phase transfer the dye.  
 
 
Figure 14: Visualization of the encapsulation of water-insoluble Para Red in water by 
block copolymer P20 (left) and visualization of the encapsulation and phase transfer of 
Orange II from the water to the DCM phase by P20 (right). 
 
Like already mentioned, using these initial visual inspections, the best results for both 
tests were obtained for polymer P20, which shows the highest ratio of hydrophilic : 
hydrophobic parts. Therefore, the phase transfer behavior (water/DCM) of P20 was 
investigated by a UV/VIS titration experiment (P20 was titrated to the biphasic mixture 
of dye and the solvents, Figure 15). The absorption of the dye in both phases was 
separately measured and the concentration of P20 was increased after each 
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measurement by addition of further aliquots. While the absorption of the dye in water 
decreased with increasing concentration P20, the absorption in DCM increased.  
 
Figure 15: UV/VIS spectra of the encapsulation and phase transfer of Orange II from 
the water phase to the DCM phase by block copolymer P20 (above: absorbance of 
Orange II in water with increasing concentration of P20, below: absorbance of 
Orange II in DCM with increasing concentration of P20). 
 
This behavior can be explained by an encapsulation and phase transfer of Orange II 
from the water to the organic phase by the amphiphilic star-shaped block 
copolymer P20. After recording a calibration curve for Orange II in water (Figure 16), 
the concentrations in water could be determined as well as the number of encapsulated 
dye molecules per polymer (Table 5). An average up to 2.50 dye molecules per 
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polymer were encapsulated when 0.10 mg/mL of P20 were added, starting with 
0.0225 mg/mL of dye in water. However, at this concentration, less than half of the 
introduced dye phase transfers to the DCM phase. A concentration of P20 of 10 mg/mL 
was required to encapsulate around 75% of the dye.  
 
 
Figure 16: UV/VIS calibration curve of Orange II in water. 
 
Table 5: Concentration of Orange II in water and DCM with increasing concentrations 
of P20 and the ratio of encapsulated dye per polymer in DCM measured via UV/VIS. 
conc. polymer 
[mg/mL] 
conc. dye in 
water [mg/mL] 
conc. dye 
in DCM 
[mg/mL] 
ratio 
polymer : 
dye in DCM 
0.00 0.0225 0.00 - 
0.10 0.0144 0.0081 1 : 2.50 
0.50 0.0128 0.0097 1 : 0.75 
1.00 0.0114 0.0111 1 : 0.38 
5.00 0.0086 0.0139 1 : 0.10 
10.00 0.0061 0.0164 1 : 0.06 
 
Finally, the hydrodynamic diameter of polymer P20 with and without guest molecule 
was compared via DLS (Figure 17). The slight increase of around 25 % and the 
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absence of larger aggregates also indicate that the guest molecules are encapsulated 
in the polymers. 
 
Figure 17: DLS results of functionalized star-shaped polymer P20 (five repeating units 
and two PEG arms (950 g/mol)): comparison of 1 mg/mL P20 in DCM without 
encapsulated dye (left) and with encapsulated dye (right). 
 
Conclusion 
In conclusion for this chapter, new unimolecular core-shell architectures were 
successfully synthesized via Passerini-3CR. Controlling the polymerization conditions, 
amphiphilic three-arm star-shaped block copolymers with Passerini derived cores and 
different PEG shells were obtained. The unimolecular behavior, the encapsulation of 
water-soluble and water-insoluble guest molecules as well as the transport abilities 
from water to an organic phase were demonstrated by UV/VIS spectroscopy and DLS 
measurements. Thus, these star-shaped block copolymers are multifunctional 
materials with a potential for applications in drug delivery systems or as phase-transfer 
catalysts. 
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4.3 Biocompatible unimolecular micelles via the Passerini-3CR for 
potential medical applications 
 
This chapter and the associated sections in the Experimental Part were submitted to 
Biomacromolecules. 
 
Parts of this project were performed at the University of Nottingham together with 
Alessandra Travanut in the working group of Prof. Dr. Alexander Cameron. 
 
 
 
Abstract 
A Passerini-3CP was performed for the synthesis of amphiphilic star-shaped block 
copolymers with hydrophobic cores and hydrophilic coronae. The degree of 
polymerization of the hydrophobic core was varied across 5-10 repeating units and the 
side chain ends were conjugated by performing a Passerini-3CR with PEG-isocyanide 
and/or PEG-aldehyde (950 g/mol). The resultant amphiphilic star-shaped block 
copolymers contained thioether groups which could be oxidized to sulfones in order to 
tune the polarity of the polymer chains. The ability of the amphiphilic copolymers to act 
as unimolecular micellar encapsulant was tested with the water-insoluble dye Orange 
II, the water-soluble dye Para Red and the macrolide antibiotic, Azithromycin. The 
results showed that the new copolymers were able to retain drug cargo at pH levels 
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corresponding to circulating blood and selectively release therapeutically effective 
doses of antibiotic as measured by bacterial cell kill. The polymers were also well-
tolerated by differentiated THP-1 macrophages in the absence of encapsulated drugs.  
 
Introduction 
Within this chapter, the above described encapsulation study[192] was extended by 
varying the polarity of the core of the star-shaped block copolymers as well as the 
number of arms of these unimolecular micelles and utilize the resultant materials to 
encapsulate and release an antimicrobial agent, Azithromycin. Polymer syntheses 
were performed via the Passerini-3CR and by using different isocyanides and core 
molecules within the Passerini-3CR, as well as oxidizing the sulfides to sulfones in the 
backbone of the polymers. Thus, the polarity as well as the architecture of the resulting 
star-shaped polymers were adjusted.  
As exemplars for the ability of these polymers to encapsulate a variety of active 
molecules, both hydrophobic dyes and Azithromycin were incorporated as guest 
molecules in formulations with the Passerini-3CR polymers. The data from 
encapsulation and release experiments clearly suggested the investigated 
unimolecular micelles showed promise as potential drug delivery systems, due to their 
good drug loading capacities and controlled release properties. In addition, as 
Passerini-3CR polymers are biodegradable polyesters, these results imply that 
developed materials of this class may find widespread future use as active carrier and 
release agents in a range of biomedical applications. 
 
4.3.1 Synthesis of amphiphilic three-armed star-shaped block 
copolymers 
 
The synthesis of star-shaped homopolymers with controlled molar masses is based on 
the introduction of a trifunctional carboxylic acid as an irreversible chain transfer 
agent 9 (ICTA) in a polymerization process of an AB-type monomer 3 (combination of 
carboxylic acid and aldehyde) and an excess of isocyanide (Scheme 35).[188, 192] The 
ratio of ICTA 9 to AB-type monomer 3 enables the prediction of the molar masses of 
the obtained polymers comparable with the initiator to monomer ratio in living controlled 
polymerization techniques. In order to investigate the encapsulation behavior of the 
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polymers, two star-shaped homopolymers P13 and P14 with different numbers of 
repeating units were synthesized as previously described (10 and 5 repeating units per 
arm), using ratios of 15:1 and 30:1 of monomer 3 and ICTA 9. 
 
 
Scheme 35: Passerini-3CR using different ratios of AB-type monomer 3 and 
trifunctional ICTA 9 and different isocyanides 5 and 24 to obtain star-shaped 
homopolymers P13, P14 and P22. 
 
The symmetric molecular weight distributions (Figure 11) and the molecular weights 
obtained by 1H NMR end group integration, which were comparable to the calculated 
molecular weights (see associated sections in the Experimental Part and Table 4), 
confirmed complete monomer conversion and the expected degrees of polymerization. 
In order to change the polarity of the star-shaped polymers in a straightforward fashion, 
methyl isocyanoacetate 24 was used as isocyanide component with the same degree 
of polymerization as P14, which leads to star-shaped polymer P22, providing more 
polar side chains. 
In order to obtain amphiphilic star-shaped block copolymers showing unimolecular 
micellar behavior, P13, P14 and P22 were post modified applying the conditions 
examined in previous studies[192] (section 4.2.2) using a water-soluble PEG-based 
(polyethylene glycol) shell (Scheme 36). Therefore, the carboxylic acid end groups of 
the star-shaped homopolymers were reacted with the previously synthesized PEG 
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aldehyde 23 (950 g/mol) and PEG isocyanide 21 (950 g/mol), to form a water-soluble 
shell owing two PEG chains attached to the arms, leading to amphiphilic star-shaped 
block copolymers. 1H NMR end group integration again confirmed full conversion to 
the desired products (see associated sections in the Experimental Part). 
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Scheme 36: Functionalization of P13, P14 and P22 with PEG isocyanide 21 
(950 g/mol) and PEG aldehyde 23 (950 g/mol) to obtain amphiphilic star-shaped block 
copolymers P20, P21 and P23. 
 
In comparison to common less polar thioethers, sulfones in general show a higher 
polarity. Interestingly, in this case, the synthesized star-shaped block copolymers have 
a sulfur containing backbone and it is known that thioethers can be easily oxidized to 
sulfones using oxidation reagents such as 3-chloroperbenzoic acid (mCPBA) or 
hydrogen peroxide.[168, 193] Consequently, besides the choice of the isocyanide, the 
polarity could be adjusted according to the desired application by simply oxidizing the 
polymers. Therefore, the sulfur containing backbones of the star-shaped block 
copolymers P20 and P23 were oxidized using two different procedures to obtain star-
shaped polymers P24 and P25 with a higher polarity. In the first procedure, mCPBA 
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was used as oxidizing agent at room temperature. In a more sustainable way, 
hydrogen peroxide was used at a higher temperature of 60 °C. The oxidation of P20 
and P23 proceeded readily leading to star-shaped block copolymers P24 and P25 with 
an increased polarity (Scheme 37). Subsequent 1H NMR analysis of the obtained 
polymers confirmed a successful oxidation of each sulfur atom. The neighboring 
protons to the sulfur showed a shift towards higher ppm values, while all the other 
signals remained unchanged (see associated sections in the Experimental Part). 
 
5
m
5
m
 
Scheme 37: Oxidation procedure of star-shaped block copolymers P20 and P23 with 
mCPBA or hydrogen peroxide to sulfone analogues P24 and P25. 
 
Furthermore, IR spectra of the reduced and oxidized star-shaped block 
copolymers P20 and P24 were recorded and compared, confirming the oxidation and 
sulfone formation (Figure 18). In principle, sulfoxides absorb at a region of 1030–
1060 cm-1, while sulfones show characteristic absorptions at 1120–1260 cm-1 and 
1300–1350 cm-1. For polymer P24 a strong absorption at 1120 cm-1 and a broad 
intensive band between 1270 and 1330 cm-1 were detected, in contrast with the 
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absorptions of the starting polymer P20. Since in the region of sulfoxide absorption no 
bands were detected, a full conversion to the corresponding sulfone was confirmed.  
 
Figure 18: IR spectra (ATR) of the relevant region of reduced and oxidized 3-armed 
star-shaped block copolymers P20 and P24. 
 
4.3.2 Synthesis of amphiphilic four-armed star-shaped block 
copolymers 
 
This chapter and the associated sections in the Experimental Part were developed in 
a “Vertieferarbeit” by Dennis Barther under supervision of Stefan Oelmann. 
 
Furthermore, it was shown that, in addition to the variation of the polarity for the desired 
unimolecular micellar behavior, the number of arms of the star-shaped polymers is 
highly relevant. Therefore, a star-shaped polymer with four arms was synthesized. In 
this case, a suitable ICTA should contain four carboxylic acid end groups to form the 
four-armed stars. In order to determine their length by 1H NMR spectroscopy, it was 
advantageous, that the ICTA compound used in the synthesis contained aromatic 
protons. These protons did not overlap with those of the backbone, due to their high 
ppm values, whereby the ratio of the protons between the core and repeating unit could 
be determined exactly. Furthermore, it was of high importance, that the corresponding 
ICTA had a good solubility in the corresponding solvent. Therefore, 3,3'5,5'-
tetracarboxydiphenylmethane 25 was chosen as the most suitable ICTA. Due to the 
good solubility, the reaction with the four-armed ICTA 25 was carried out in THF. The 
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reaction time had to be increased to 72 h (Scheme 38). Again, by performing this 
reaction, it was shown that the number of repeating units can be varied selectively and 
easily by varying the ratio of ICTA 25 to AB-type monomer 3. Different four-armed star-
shaped homopolymers with 5 repeating units per arm ([3]:[25], 5:1 per arm P26) and 
with 10, 20 and 30 repeat units per arm ([3]:[25], 10:1 P27, 20:1 P28, 30:1 P29 per 
arm) could be synthesized.  
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Scheme 38: Synthesis of different four-armed star-shaped homopolymers and the 
following functionalization to obtain amphiphilic four-armed star-shaped 
copolymer P31. 
 
It was also shown, that the symmetric molecular weight distribution shifts towards 
smaller retention times with increasing arm length or with increasing hydrodynamic 
radius (Figure 19). 1H NMR analysis of the resulting polymers P26–P29 showed an 
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excellent correlation of the aromatic proton signals of the ICTA and the signals of the 
repeating units (see associated sections in the Experimental Part and Table 6).  
 
Figure 19: SEC results of four-armed star-shaped homopolymers P26, P27, P28 and 
P29 with varying ratio of AB-type monomer 3 and four-armed ICTA 25 (P26 = 5:1, 
P27 = 10:1, P28 = 20:1, P29 = 30:1 per arm). 
 
Table 6: Molecular weights of four-armed star-shaped homopolymers P26, P27, P28 
and P29 synthesized with different ratios of AB-type monomer 3 and four-armed 
ICTA 25. 
polymer 
ratio 
[3]:[25] 
Mn calc. 
[g/mol] 
Mn NMR 
[g/mol] 
Mn 
SEC 
[g/mol] 
Ð 
Mw/Mn 
P26 5:1 7,495 7,538 7,900 1.33 
P27 10:1 14,646 14,149 14,400 1.30 
P28 20:1 28,948 28,927 15,100 1.47 
P29 30:1 43,250 43,379 16,100 1.49 
 
 
Additionally, it was shown, that it is also possible to obtain four-armed star-shaped 
polymers with different side groups, dependent on the choice of isocyanide. This was 
performed in order to vary the polarity of the polymer as well. Therefore, the reaction 
was tested with methyl isocyanoacetate 24 and 5 repeating units per arm to finally 
obtain star-shaped homopolymer P30. The functionalization with PEG isocyanide 21 
and PEG aldehyde 23 resulted in a hydrophilic shell around the hydrophobic core, 
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leading to amphiphilic four-armed star-shaped block copolymer P31 (Scheme 38). The 
previously synthesized star-shaped homopolymer P26 was used as four-armed acid 
component within the Passerini-3CR. 
 
4.3.3 Polarity characterization and dye encapsulation studies of 
amphiphilic star-shaped block copolymers 
 
Thereafter, the octanol-water partition coefficients (P) of the reduced and oxidized 
three-armed star-shaped copolymers P20, P23, P24 and P25 and two dyes (Orange II 
and Para Red) were determined. The octanol-water partition coefficient (P) directly 
correlates with the polarity of the chemical substrates. An easy and fast method to 
obtain the polarity of a substance is the indirect determination of partition coefficients 
from chromatographic retention data, using the reverse phase HPLC (RP-HPLC) 
method.[161] Therefore, octanol was displaced by a mixture of methanol and 
water (70:30) as eluent.[194] The HPLC system was calibrated with different substances 
of known P.[195] To determine the dead time of the column, which is defined as the time 
needed for a compound not interacting with the stationary phase while passing the 
column (t0), thiourea was chosen. By using t0 and t (retention time of the polymers), 
the capacity factor k, which is described as the retention of a substance, can be 
calculated and is defined as followed: 
 
) = *+*,*,   
 
The linear relation between k and the octanol-water partition coefficient, enabled the 
experimental value of P to be easily determined.  
Figure 20 shows the obtained results for P20, P23, P24 and P25 compared to the two 
dyes Orange II and Para Red. Oxidation of the star-shaped polymers increased their 
polarity, as indicated by a negative value of log k of P24 and P25. Using methyl 
isocyanoacetate 22 instead of tert-butyl isocyanide 5 also increased the polarity. 
Interestingly, Para Red was of a similar polarity as the starting polymers, and Orange II 
showed a comparable polarity to the oxidized polymers.  
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Figure 20: RP-HPLC determination of octanol water partition coefficients of reduced 
and oxidized three-armed star-shaped block copolymers P20, P23, P24 and P25 
compared with Orange II and Para Red. 
 
In a further test, the encapsulation ability of the star-shaped block copolymers P20, 
P23, P24 and P25, possessing different polarities, was investigated by UV/VIS 
measurements (Figure 21) using water insoluble Para Red in water and Orange II 
(insoluble in DCM) in DCM. An excess of 10 molecules Orange II per star-shaped 
polymer molecule (5.00 mg) was added to 5.00 mL DCM, in which it is not soluble. 
After addition of the star-shaped polymer, the dye was encapsulated and dissolved in 
DCM (i.e. within the core of the star-shaped block copolymer). Afterwards, the non-
encapsulated dye molecules were filtered off and the UV/VIS absorption of the 
resultant orange solution was carried out. The test was performed with the reduced 
and oxidized star-shaped block copolymers P20, P23, P24 and P25. The same 
preparation and measurement was repeated using water-insoluble Para Red as dye in 
water. The encapsulation was expected to be more efficient, if the polarity of polymers 
and dye were similar. It could thus be shown, that the encapsulation of the more polar 
Orange II was more efficient using oxidized star-shaped block copolymers P24 and 
P25. On the other hand, the encapsulation of Para Red was better with the reduced 
star-shaped block copolymers P20 and P23. Due to the insolubility of Orange II in 
DCM, it was not possible to record a calibration curve, which is why these results are 
relative to each other. Summarizing, this is a clear proof that the polarity of the star-
shaped polymers can be tuned by using different polar isocyanides and by oxidizing 
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the polymer backbone. Furthermore, it could be shown, that the polarity significantly 
affected the encapsulation behavior.  
 
Figure 21: UV/VIS spectra of the encapsulation of Orange II in DCM by reduced and 
oxidized star-shaped block copolymers P20, P23, P24 and P25 (above), water 
insoluble Para Red in water by reduced and oxidized star-shaped block 
copolymers P20, P23, P24 and P25 (below). 
 
The same set of polymers were used again to visualize the polarity within a 
solvatochromism experiment.[196] The effect of solvatochromism describes the ability 
of a chemical substrate to change its color depending on the polarity of the solvent in 
which it is dissolved.[197] The Reichardt's dye shows one of the largest solvachromic 
effects with a color change over the whole visible spectrum.[198] The star-shaped block 
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copolymers P20, P23, P24 and P25 were able to encapsulate this dye and, due to the 
different microenvironment within their core, the different colors were made visible 
through the solvatochromism effect of the dye (Figure 22, above).  
 
 
Figure 22: Pictures (above) and UV/VIS spectra (below) of the encapsulation of 
Reichardt‘s Dye in DCM by reduced and oxidized star-shaped block copolymers P20, 
P23, P24 and P25 showing different wavelength maxima, due to their different polarity 
and due to the solvatochromism effect of the encapsulated dye. 
 
These visual results, confirmed by UV/VIS absorption experiments, showed different 
wavelength maxima, due to the different polarity of the star-shaped block copolymers 
(Figure 22, below). The higher the polarity, the lower was the wavelength maximum. 
Therefore, the Reichardt’s dye was encapsulated (one molecule per star-shaped 
polymer) in 5.00 mL DCM and the UV/VIS absorption measured, using 5.00 mg of the 
reduced and oxidized three-armed star-shaped block copolymers P20, P23, P24 and 
P25.  
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4.3.4 Comparison of the encapsulation behavior of four-armed and three-
armed star-shaped polymers 
 
Furthermore, it was shown that not only the polarity has an influence on the 
encapsulation behavior, but also the number of arms. Therefore, Orange II was added 
to 10.0 mL of a water/DCM biphasic system. Orange II was soluble in the water phase, 
but not in the DCM phase. After addition of four-armed star-shaped block copolymer 
P31 and shaking, the dye was encapsulated and phase-transferred to the DCM phase 
(Figure 23). These results were compared to previous results of amphiphilic three-
armed star-shaped block copolymer P20 in former studies (section 4.3.2). The phase 
transfer behavior was additionally investigated by a UV/VIS experiment (Figure 24). In 
both solvent phases, the absorption was measured separately, and it could be shown 
that P31 could encapsulate more dye, due to the higher number of arms. The 
absorption of the dye, using P31, was higher in DCM, whereas it was lower in the water 
phase as compared to the results for P20. 
 
 
Figure 23: Picture of the encapsulation and phase transfer of Orange II from the water 
phase to the DCM phase by three-armed star-shaped block copolymer P20 and four-
armed star-shaped block copolymer P31. 
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Figure 24: UV/VIS spectra of the encapsulation and phase transfer of Orange II from 
the water phase to the DCM phase by three-armed star-shaped block copolymer P20 
and four-armed star-shaped block copolymer P31 (above: absorbance of Orange II in 
water, below: absorbance of Orange II in DCM). 
 
4.3.5 In vitro drug loading and release efficiency studies of amphiphilic 
star-shaped block copolymers 
 
The preparation methods of the following studies can be seen in the associated 
sections of the Experimental Part. All results described in this subchapter are a result 
of a collaboration with the group of Prof. Alexander Cameron at the University of 
Nottingham, UK.  
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Azithromycin is a semi-synthetic macrolide antibiotic, which is extensively used in the 
treatment of respiratory tract and skin infections (Figure 25). This drug is slightly water-
soluble, with a similar solubility profile to many approved active pharmaceutical 
ingredients, and has good bioavailability in both oral and injectable formulations.[199] 
However, for pediatric settings, where dosing is more critical and the gap between toxic 
and minimum therapeutic levels is much lower, a sustained release formulation of 
Azithromycin is highly desirable.[200] Owing to the widespread existing use of polyester 
materials in controlled release formulations,[201] we therefore were interested in the 
ability of the Passerini-3CR star-shaped block copolymers to encapsulate the 
Azithromycin molecule in a unimolecular micelle formulation, and to release it under 
physiologically relevant conditions. Azithromycin was here tested as a hydrophobic 
drug model. 
 
 
Figure 25: Structure of Azithromycin 
 
The Azithromycin loading, encapsulation efficiency and polymer to drug molar ratio 
were calculated using the following equations: 
 
-./0	1234560	% = 8950ℎ;	2<	123494	4./0=2;31	>950ℎ;	2<	?5@9119A B	100 
 
-./0	96@3CA/13;526	%	>/> = =2;31	3?2/6;	2<	4./0 − F6123494	4./0=2;31	3?2/6;	2<	4./0 	B	100 
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The results for the star-shaped block copolymers P20, P21, P23, P24, P25, and P31 
were summarized in Table 7. The highest drug loading was observed for P31. This 
confirmed, that the encapsulation ability was affected by the number of arms of the 
star-shaped block copolymer. The results of P21 further confirmed how the drug 
encapsulation could be improved by increasing the number of homopolymer repeating 
units. P20, P23, P24 and P25 data showed, how the drug loading could be driven, not 
only by the hydrophobic but also by the hydrogen-bonding interactions. The high drug 
encapsulation observed for P24 and P25 (compared to P20 and P23 respectively) 
suggested, that the sulfone groups were interacting as hydrogen bond acceptors with 
the seven hydrogen bond donors of Azithromycin (Figure 25). In contrast, P20 and P23 
showed low drug encapsulation.  
 
Table 7: Drug loading and encapsulation efficiency data of P20, P21, P23, P24, P25 
and P31 (SD = standard deviation, pol:Az = polymer:Azithromycin). 
polymer 
drug loading 
(wt%) ± SD 
encapsulation 
efficiency 
(%) ± SD 
molar ratio 
pol:Az 
P20 8.00 ± 1.24 8.09 ± 2.14 1 : 1.35 
P21 25.3 ± 1.06 30.37 ± 3.24 1 : 5.00 
P23 8.90 ± 0.4 11.74 ± 1.78 1 : 1.32 
P24 17.7 ± 0.8 44.13 ± 2.03 1 : 2.68 
P25 21.9 ± 1.3 38.00 ± 2.95 1 : 3.36 
P31 35.0 ± 0.6 42.06 ± 1.20 1 : 6.00 
 
The drug release profile of P31 (Figure 26) was studied at pH 7.4 (blood pH) and pH 5 
(lysosomal pH). It was found that at pH 7.4 only 20 % of the loaded Azithromycin was 
released in 5 hours and the remaining content was retained over three days. It was 
observed that at pH 5 the drug was completely released within 2 hours. These results 
suggested that Azithromycin, as a weakly dibasic antibiotic,[202] was protonated at 
acidic pH and thus released faster than at pH 7.4. These studies impressively showed 
how P31 could potentially retain the loaded drug during circulation in the bloodstream 
(blood, pH 7.4), but selectively and completely release it inside acidified intracellular 
compartments (lysosomes, pH ~ 5) or in regions of enhanced acidity at infection sites.  
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Figure 26: Analysis of Azithromycin release from star-shaped block copolymer P31 at 
above: pH 7.4 (blood mimicking, above) and below: pH 5 (lysosome mimicking, below).  
 
4.3.6 Viability, bacterial susceptibility and cellular uptake studies of 
amphiphilic star-shaped block copolymers 
 
All experiments and results described in this subchapter were performed and 
described by Alessandra Travanut from Nottingham and shown here to demonstrate a 
possible application of the novel unimolecular micelles. 
The preparation methods of the following studies can be seen in the associated 
sections of the Experimental Part. 
4. Results and Discussion 
 
 
82 
Afterwards a CellTiter-FluorTM cell viability assay was performed to assess the effects 
of star-shaped block copolymer P31 in THP-1 macrophage differentiated cells over an 
incubation period of 72 hours. Untreated cells, cells exposed to highly lytic surfactants 
and polymer solutions were tested as controls. It was found that P31 did not have any 
cytotoxic effect as measured by the CellTiter-FluorTM assay, thus suggesting this 
polymer was well-tolerated by THP-1 differentiated macrophages (Figure 27).  
 
Figure 27: Viability Assay showing the protease activity of differentiated THP-1 cells 
treated with different concentrations of P31. Untreated Control: cells untreated with 
P31. 
 
The antibiotic activity of the free and encapsulated Azithromycin in P31 was assessed 
by performing a susceptibility assay with the common opportunistic pathogen 
Staphyloccocus aureus (Figure 28). It was observed that the bacteriostatic activity of 
the encapsulated drug was the same of the free drug, suggesting that the 
encapsulation did not affect the Azithromycin antibiotic activity. This assay was 
repeated three times with reproducible results; untreated wells and wells 
supplemented with solvent or polymer were set as controls. 
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Figure 28: Effect of encapsulated Azithromycin on Staphyloccocus aureus growth. 
Bacteriostatic activity of serial concentrations (100-0.1 µg/mL) of free 
Azithromycin (Az) or P31-encapsulated Azithromycin (PAz) were assessed in TSB 
cultures. Values given are averages from three different cultures ± standard deviation 
and correspond to the area under the curve derived from plotting single OD600 
measurements over time (24 h), and as percentage of the corresponding growth 
obtained in the untreated controls (set at 100 %). Controls wells Az 0 µg/mL and Paz 
0 µg/mL were supplemented with solvent or only P31 respectively. 
 
Confocal laser scanning microscopy was performed in order to assess the intracellular 
localization of the cargo carried by star-shaped copolymer P31. Differentiated THP-1 
macrophages were incubated for 1 hour with P31, loaded with Oregon-green 
(100 µg/mL; Synthesis see associated sections in the Experimental Part)[208] (Figure 
29). It was observed that the green fluorescence (Oregon-green) is localized in the 
cytoplasm (Figure 29C), thus the star-shaped copolymer P31 was able to deliver its 
cargo inside the cells. 
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Figure 29: Confocal laser scanning microscopic images of cellular uptake in 
macrophage differentiated THP-1 cells cultured with Oregon-green loaded P31 
unimolecular micelles. (A) Staining protocol I (see associated sections in the 
Experimental Part) and (B) Staining protocol II (see associated sections in the 
Experimental Part). (C) Figure B section and zoom. Nuclei of cells were stained with 
Hoechst (blue fluorescence), cells membranes were stained with CellMaskTM deep 
red plasma membrane stain (red fluorescence) and F-actin was stained with Alexa 
FluorTM 647 Phalloidin (red fluorescence). 
 
Conclusion 
In conclusion, a library of amphiphilic star-shaped block copolymers via Passerini-3CR 
reactions was prepared. The polarity of the hydrophobic block was increased by 
oxidizing the sulfide groups to sulfones leading to the encapsulation of hydrophobic 
and hydrophilic molecules respectively. It was found that the encapsulation ability was 
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not only related to the polarity, but also to the number of arms of the hydrophobic core 
of the star-shaped copolymers. For the antimicrobial drug Azithromycin, the drug 
loading was found to be 35 mol%, which, considering the physical properties of 
Azithromycin are analogous to many other active pharmaceutical ingredients, suggests 
a potential biomedical application for the amphiphilic star-shaped block copolymers 
presented in this study. The polymers were found to be well tolerated by macrophages, 
which are the first cells to internalize most injected formulations and the sanctuary sites 
for many bacterial pathogens. Furthermore, the Passerini polymers were able to retain 
Azithromycin within their unimolecular micellar structure at pH levels found in the 
bloodstream but release the drug under acidic pH values similar to those in intracellular 
digestive compartments. Finally, the activity of the drug, when delivered from the 
unimolecular micelle formulations, was fully retained in terms of bacterial cell kill, as 
susceptibility assays using the common pathogen Staphylococcus aureus showed. In 
summary, these results clearly suggest the investigated unimolecular micelles have 
potential as easy-to-synthesize, cytocompatible drug delivery systems, with good drug 
loading and release properties. 
 
 
5. Conclusion and Outlook 
 
86 
5. CONCLUSION AND OUTLOOK 
 
In summary, a new and versatile approach for the synthesis of three- and four-armed 
star-shaped polymers with defined molecular weights and adjustable polarity by a non-
classic step-growth polymerization technique was developed. These polymers, 
synthesized via the Passerini-3CR, were used as unimolecular micelles and the 
encapsulation and phase transfer behavior of different dyes were tested. Furthermore, 
the drug loading capacities, the controlled release properties and the biocompatibility 
of the Passerini-polymers were investigated, using a macrolide antibiotic 
(Azithromycin) to show the potential as drug delivery system. 
Therefore, an AB-type monomer containing an aldehyde and carboxylic acid end group 
was synthesized and polymerized via a Passerini-3CR with different isocyanides and 
a linear ICTA. With this simple polyaddition process, α-amide substituted polyesters 
with controlled molecular weights were synthesized. Due to the still active carboxylic 
acid end groups, diblock copolymers could be synthesized in a further Passerini 
reaction. Using a trifunctional ICTA, three-armed star-shaped homopolymers could be 
obtained in the same way. To obtain unimolecular core-shell architectures with an 
amphiphilic behavior, these star-shaped polymers were functionalized via a Passerini-
3CR with different PEG-based shells. The unimolecular behavior, the encapsulation of 
water-soluble and water-insoluble guest molecules as well as the transport abilities 
from water to an organic phase were successfully tested. Afterwards, the polarity of 
the hydrophobic core block was increased by oxidizing the sulfide groups of the 
polymer backbone to sulfones and by using isocyanides of different polarity to tune the 
properties of these multifunctional materials. It could be shown that the encapsulation 
and transport properties of different polar guest molecules could be influenced by the 
polarity of the polymers. It was also demonstrated that the encapsulation ability was 
not only related to the polarity but also to the number of arms of the star-shaped 
copolymers. Therefore, four-armed star-shaped polymers were synthesized, examined 
and compared to three-armed analogous. Thus, a library of defined amphiphilic star-
shaped block copolymers was synthesized via Passerini-3CR reactions in a 
straightforward fashion. To evaluate the potential of these easy-to-synthesize polymers 
for applications as drug delivery system, the drug loading capacity was tested with the 
antimicrobial drug Azithromycin. Depending on the polymer, up to six drug molecules 
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per polymer could be encapsulated. Furthermore, the Passerini polymers were able to 
retain Azithromycin within their unimolecular micellar structure at a pH found in the 
bloodstream but release the drug under acidic pH similar to those found in 
macrophages. The biocompatibility of these star-shaped polymers was successfully 
tested, revealing that these polymers were well tolerated by macrophages. Finally, it 
could be demonstrated that the activity of the drug was fully retained while delivered 
from the amphiphilic Passerini star-shaped block copolymers. 
For the future, the herein presented novel non-classic step-growth polymerization 
technique offers diverse opportunities to synthesize new well defined macromolecular 
architectures for a wide variety of applications. The number of arms and the size of the 
core and shell of these star-shaped polymers could be increased to encapsulate more 
and/or larger guest molecules. Thereby, these systems could be tested with anticancer 
drugs or in the field of phase transfer catalysis. In addition to the Passerini-3CR, other 
multicomponent reactions, like the Ugi or the Biginelli reaction could be tested in an 
analogous procedure to obtain unimolecular micelles with different architectures and 
new properties. Furthermore, the synthesis of monodisperse star-shaped polymers 
using the Passerini-3CR in a sequence defined way could provide more accurate 
information about the encapsulation and release behavior. Another attractive 
possibility would be the introduction of chirality by using chiral core molecules or by 
synthesizing chiral arms, due to the very interesting properties of chiral materials, 
which can be used in stereoselective catalysis. 
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6. EXPERIMENTAL PART 
 
6.1 Materials 
 
The following chemicals were used as received: 10-undecenal (≥90%, Aldrich), 3-
mercaptopropionic acid (≥99%, Aldrich), 2,2-dimethoxy-2-phenylacetophenone 
(DMPA, 99%, Aldrich), 10-undecenoic acid (98%, Aldrich), cyclohexyl isocyanide 
(98%, Aldrich), tert-butyl isocyanide (98%, Aldrich), benzyl isocyanide (98%, Aldrich), 
pentyl isocyanide (98%, Aldrich), tert-butyl 2-isocyanoacetate (98%, Aldrich), trimesic 
acid (95%, Aldrich), O-Methyl-O′-[2-(6-oxocaproylamino)ethyl]polyethylene glycol 
2000, (PEG aldehyde 2000, Aldrich), 11-aminoundecanoic acid (97%, Aldrich), 
methanol (99%, Aldrich), thionyl chloride (97%, Aldrich), trimethyl orthoformate (99%, 
Aldrich), diisopropyl amine (99%, Aldrich), phosphorus(V) oxychloride (99%, Aldrich), 
1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD, 98%, Aldrich), poly(ethylene glycol) methyl 
ether 750 (Methoxy PEG 750, Aldrich), poly(ethylene glycol) methyl ether thiol 800 
(PEG thiol 800, Aldrich), Orange II sodium salt (85% dye content, Aldrich), Para Red 
(95% dye content, Aldrich), Reichardt’s dye (90%, Aldrich), 3-chloroperbenzoic acid 
(mCPBA, 77%, Aldrich), hydrogen peroxide solution (30% in water, Aldrich), methyl 
isocyanoacetate (95%, Aldrich), 3,3,5,5-tetracarboxydiphenylmethane (95%, Aldrich), 
silica gel 60 (0.035–0.070, Aldrich), chloroform-d (CDCl3, 99.8 atom-% D, euriso-top), 
methanol-d4 (99.8 atom-% D, euriso-top), CellTiter-FluorTM Cell Viability Assay 
(Promega, Madison WI), Azithromycin (PHR1088, Aldrich), Tween® 20 (P1379, 
Aldrich), Dulbecco’s Phosphate Buffered Saline - PBS (Aldrich), Citric Acid (C-3674, 
Aldrich), Slide-A-Lyzer® MINI Dialysis Units (Thermo SCIENTIFIC), Phorbol 12-
myristate 13-acetate (PMA) (99%, Aldrich), Penicillin/Streptomycin (Aldrich), L-
Glutamine (Aldrich), THP-1 human cells were purchased from ATCC in frozen from 
(Manassas, VI, USA), RPMI-1640 media and fetal bovine serum were obtained from 
Life Technologies (Carlsbad, CA, USA). All solvents used were of technical grade. 
  
  6. Experimental Part 
 
 
89 
6.2 Instrumentation 
 
Thin-layer chromatography (TLC) identification of reactants and products was 
performed on silica-gel-coated aluminum foil (Aldrich, silica gel 60, F 254 with 
fluorescence indicator). Compounds were visualized by Seebach reagent (mixture of 
phosphomolybdic acid, cerium(IV) sulfate, water and sulfuric acid). 
NMR spectra were recorded on a Bruker AVANCE DPX spectrometer (measuring 
frequency: 1H NMR = 300 MHz, 13C NMR = 75 MHz) or a Bruker AMX R 500 
spectrometer (measuring frequency: 1H NMR = 500 MHz, 13C NMR = 126 MHz). NMR 
spectra were obtained using CDCl3. All 1H NMR spectra are reported in ppm relative 
to the solvent signal for CDCl3 at 7.26 ppm, 13C NMR spectra are reported relative to 
the solvent signal for CDCl3 at 77.16 ppm. 
Polymers were characterized on a SEC System LC-20A (Shimadzu) equipped with a 
SIL-20A autosampler and a RID-10A refractive index detector using THF (flow rate 
1 mL/min) at 50 °C. The analysis was performed on the following column system: 
analytical main-column PSS SDV (5 µm, 300 mm × 8.0 mm, 10,000 Å) with a PSS 
SDV analytical precolumn (5 µm, 50 mm × 8.0 mm). For the calibration narrow linear 
poly(methyl methacrylate) standards (Polymer Standards Service PPS, Germany) 
ranging from 1.1 to 981 kDa were used.  
FAB (fast atom bombardment) mass spectra were recorded on a MAT95 (Finnigan) 
instrument.  
Infrared (IR) spectra were recorded on a Bruker alpha-p instrument applying KBr- as 
well as ATR-technology. 
The thermal properties of the prepared polymers were studied via DSC (differential 
scanning calorimetry) with a Mettler Toledo DSC star system, operating under nitrogen 
atmosphere and using about 5 mg of the respective polymer for the analysis. The glass 
transition temperature (Tg) was recorded on the second heating scan by using the 
following method: heating from −70 to 150 °C at 10 °C min−1, cooling from 150 to 
−70 °C at 10 °C min−1, and heating from −70 to 150 °C at 10 °C min−1. 
Size exclusion chromatography–electrospray ionization–mass spectra (SEC–ESI–MS) 
were recorded on a Q Exactive (Orbitrap) mass spectrometer (Thermo Fisher 
Scientific, San José, CA, USA) equipped with an HESI II probe. The instrument was 
calibrated in the m/z range 74–1822 using premixed calibration solutions (Thermo 
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Scientific). A constant spray voltage of 4.6 kV, a dimensionless sheath gas of 8, and a 
dimensionless auxiliary gas flow rate of 2 were applied. The capillary temperature and 
the S-lens RF level were set to 320 °C and 62.0 °C, respectively. The Q Exactive was 
coupled to an UltiMate 3000 UHPLC System (Dionex, Sunnyvale, CA, USA) consisting 
of a pump (LPG 3400SD), autosampler (WPS 3000TSL), and a thermostated column 
department (TCC 3000SD). Separation was performed on two mixed bed size 
exclusion chromatography columns (Polymer Laboratories, Mesopore 250 × 4.6 mm, 
particle diameter 3 µm) with precolumn (Mesopore 50 × 4.6 mm) operating at 30 °C. 
THF at a flow rate of 0.30 mL min−1 was used as eluent. The mass spectrometer was 
coupled to the column in parallel to a RI-detector (RefractoMax520, ERC, Japan). 
0.27 mL min−1 of the eluent were directed through the RI-detector and 30 µL min−1 
infused into the electrospray source after post column addition of a 100 µM solution of 
sodium iodide in methanol at 20 µL min−1 by a micro-flow HPLC syringe pump 
(Teledyne ISCO, Model 100DM). A 20 µL aliquot of a polymer solution with a 
concentration of 2 mg mL−1 was injected onto the HPLC system. 
Dynamic light scattering (DLS) was performed on a Zeta Sizer Nano S (Malvern 
Instruments) with a scattering angle of 176.1°. The reported diameter (dDLS) is an 
intensity-weighted average size (z-average), comprised of ﬁve to nine measurements 
analyzed in 10 to 20 runs. The reported polydispersity index values (PDDLS) are those 
given by the instrument and are referred to as Malvern polydispersity. 
A UV/VIS spectrometer of the type Cary 60 from Agilent Technologies was used to 
record UV/VIS spectra. It scanned the entire wavelength range (190 to 1100 nm) in 
under three seconds and collect data from single or multiple wavelengths at 80 data 
points per second. The measurements were performed in water and DCM. Therefore, 
a 10 mm Semi-Micro Quartz Cuvette was used. 
HPLC measurements were performed using an Agilent HPLC 1200 system equipped 
with a MZ Refill PerfectSil Target ODS-3 5 mm column (4.0 x 250 mm) and a DAD 
detector. A mixture of methanol and water (70:30) was used as eluent with a flow rate 
of maximum 5.0 mL/min and an injection volume of maximum 100 µL. 
The cellular uptake of unimolecular micelles was observed using a Carl Zeiss LSM 700 
BW microscope. A 488 nm wavelength laser was used to excite the Oregon-green 
(excitation/emission maxima = 495/521 nm). AlexaFluor 647 far red F-actin stain 
(excitation/emission maxima = 650/665 nm) and CellMaskTM deep red plasma 
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membrane stain (excitation/emission maxima = 649/666 nm) were excited with a laser 
of 633 nm wavelength. The Hoechst 33342 stain (excitation/emission maxima = 
350/462 nm) was illuminated with a 100-Watt high-pressure mercury plasma arc-
discharge lamp (HBO 100). Oregon-green polymer-free (100 µg/mL) treated cells were 
used as control.  
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6.3 Experimental procedures – chapter 4.1 
 
Synthesis of AB-type monomer 3 via thiol-ene reaction 
 
10-undecenal 1 (1.68 g, 10.0 mmol) and DMPA (130 mg, 0.50 mmol) were dissolved 
in 4.0 mL THF. After purging with argon for 10 minutes, the solution was exposed to 
UV light (365 nm) for 30 s. Subsequently, 3-mercaptopropionic acid 2 (1.17 g, 959 µL, 
11.0 mmol) was slowly added and the reaction mixture was stirred for 2 h under UV 
irradiation. After evaporating the solvent under reduced pressure, the crude product 
was purified by silica gel column chromatography (n-hexane/ethyl acetate = 3:1 – 1:1) 
to yield a white solid (2.10 g, 77 %). Rf = 0.30 (dichloromethane/methanol = 20:1); 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.21–1.41 (m, 12 H, 6 CH2), 1.51–1.69 (m, 4 H, 
2 CH2), 2.42 (td, J = 7.3, 1.7 Hz, 2 H, CH2CHO), 2.53 (t, J = 7.3 Hz, 2 H, CH2S), 2.61–
2.70 (m, 2 H, CH2COOH), 2.73–2.82 (m, 2 H, SCH2), 9.76 (t, J = 1.8 Hz, 1 H, CHO); 
13C NMR (CDCl3, 75 MHz): δ (ppm) = 22.13, 26.67, 28.88, 29.20, 29.22, 29.37, 29.39, 
29.47, 29.56, 32.25, 34.78, 178.12, 203.31; FAB of C14H26O3S [M+H]+ = 275.1; HRMS 
(FAB) of C14H26O3S [M+H]+ calc. 275.1681, found 275.1680; IR (KBr) ν = 2914.7, 
2847.2, 2742.6, 1708.0, 1684.7, 1466.7, 1407.2, 1338.2, 1263.9, 1197.5, 1064.0, 
915.4, 894.3, 761.7, 737.7, 721.1, 696.0, 660.8, 490.5 cm-1; Tm = 70 °C. 
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Synthesis of homopolymers P1-P4 via Passerini-reaction 
 
General procedure: To a vigorously stirred solution of 10-undecenoic acid 4 (13.3 mg, 
0.0722 mmol) and the corresponding isocyanide 5-8 (7.20 mmol), the AB-type 
monomer 3 (400 mg, 0.36 mmol) in 1.0 mL dichloromethane (DCM) was added slowly. 
After stirring for 24 hours at room temperature, the polymer was precipitated from 
diethyl ether. 
 
Homopolymer P1  
Following the aforementioned procedure, P1 was obtained as a white solid (96 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.20–1.32 (m, 280 H, 140 CH2), 1.35–1.42 (m, 
196 H, 180 t-Bu, 8 CH2 end group), 1.52–1.62 (m, 40 H, 20 CH2CH2S), 1.75–1.88 (m, 
40 H, 20 CHCH2), 2.53 (t, J = 7.4 Hz, 40 H, 20 CH2S), 2.69 (t, J = 6.5 Hz, 40 H, 20 
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SCH2), 2.81 (t, J = 6.2 Hz, 40 H, 20 CH2COO), 4.87–5.00 (m, 2 H, CH2 double bond), 
5.07 (t, J = 6.2 Hz, 20 H, OCH(CO)), 5.93–6.03 (m, 1 H, CH double bond), 6.09 (s, 20 
H, NH); Tg = 5 °C. 
 
 
Homopolymer P2 
Following the aforementioned procedure, P2 was obtained as sticky yellow solid 
(81 %). 1H NMR (CDCl3, 300 MHz): δ (ppm) = 0.84–0.92 (m, 60 H, 20 CH3), 1.23–1.38 
(m, 376 H, 180 CH2, 8 CH2 end group), 1.45–1.61 (m, 80 H, 20 CH2CH2S, 20 
NHCH2CH2), 1.75–1.91 (m, 40 H, 20 CHCH2), 2.53 (t, J = 7.4 Hz, 40 H, 20 CH2S), 
2.67–2.75 (m 40 H, 20 SCH2), 2.79–2.91 (m, 40 H, 20 CH2COO), 3.18–3.29 (m, 40 H, 
20 CHCH2), 4.92–4.97 (m, 2 H, CH2 double bond), 5.16–5.23 (m 20 H, OCH(CO)), 
5.98–6.07 (m, 1 H, CH double bond), 6.57 (t, J = 6.2 Hz, 20 H, NH); Tg = –11 °C. 
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Figure 30: Mass spectra of homopolymer P2 with n repeating units and a calculated 
mass of 371.580 g/mol per repeating unit (a = retention time of 13.17 min, b = retention 
time of 11.94-13.93 min, c = calculated isotope pattern, d = experimental isotope 
pattern at a retention time of 13.17 min). 
 
Homopolymer P3 
Following the aforementioned procedure, P3 was obtained as sticky colorless solid 
(81 %). 1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.20–1.43 (m, 412 H, 198 CH2, 8 CH2 
end group), 1.56–1.75 (m, 132 H,66 CH2), 1.80–1.89 (m, 88 H, 22 CH2CH2S, 22 
CHCH2), 2.54 (t, J = 7.4 Hz, 44 H, 22 CH2S), 2.65–2.74 (m, 44 H, 22 SCH2), 2.77–
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2.88–2.99 (m, 44 H, 22 CH2COO), 3.69–3.82 (m, 22 H, NCH) 4.89–4.94 (m, 2 H, CH2 
double bond), 5.11–5.20 (m, 22 H, OCH(CO)), 5.29–5.34 (m, 1 H, CH double bond), 
6.35 (d, J = 8.2 Hz, 22 H, NH); Tg = 3 °C. 
 
 
 
Figure 31: Mass spectra of homopolymer P3 with n repeating units and a calculated 
mass of 383.249 g/mol per repeating unit (a = retention time of 13.16 min, b = retention 
time of 11.74-13.83 min, c = calculated isotope pattern, d = experimental isotope 
pattern at a retention time of 13.16 min). 
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Homopolymer P4 
Following the aforementioned procedure, P4 was obtained as sticky brown solid 
(92 %). 1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.15–1.46 (m, 304 H, 144 CH2, 8 CH2 
end group), 1.81–1.95 (m, 36 H, 18 CHCH2), 2.34 (t, J = 7.3 Hz, 36 H, 18 CH2S), 2.63–
2.72 (m, 36 H, 18 SCH2), 2.74–2.84 (m, 36 H, 18 CH2COO), 4.41–4.49 (m, 36 H, 18 
NCH2) 4.95–4.99 (m, 2 H, CH2 double bond), 5.23–5.31 (m, 18 H, OCH(CO)), 5.73–
5.84 (m, 1 H, CH double bond), 6.96–7.04 (m, 18 H, NH), 7.11–7.24 (m, 36 H, 36 Ar-
H), 7.28–7.39 (m, 54 H, 54 Ar-H); Tg = 1 °C. 
 
 
Synthesis of homopolymers P5-P7 via Passerini-reaction 
 
General procedure: To a vigorously stirred solution of 10-undecenoic acid 4 
(1.00 equiv.) and isocyanide 5 (50, 150, 200 equiv.), the AB-type monomer 3 (10, 30, 
40 equiv.) in 1.50 mol/L dichloromethane (DCM) was added slowly. After stirring for 
24 hours at room temperature, the polymer was precipitated from diethyl ether. 
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Homopolymer P5  
Following the aforementioned procedure, P5 was obtained as a white solid (93 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.20–1.32 (m, 140 H, 70 CH2), 1.35–1.45 (m, 
106 H, 90 t-Bu, 8 CH2 end group), 1.52–1.62 (m, 20 H, 10 CH2CH2S), 1.75–1.88 (m, 
20 H, 10 CHCH2), 2.53 (t, J = 7.3 Hz, 20 H, 10 CH2S), 2.69–2.77 (m, 20 H, 10 SCH2), 
2.81–2.92 (m, 20 H, 10 CH2COO), 4.87–5.00 (m, 2 H, CH2 double bond), 5.07–5.18 
(m, 10 H, OCH(CO)), 5.93–6.03 (m, 1 H, CH double bond), 6.09 (s, 10 H, NH). 
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Figure 32: Mass spectra of homopolymer P5 with n repeating units and a calculated 
mass of 357.234 g/mol per repeating unit (a = retention time of 14.27 min, b = retention 
time of 12.76-14.28 min, c = calculated isotope pattern, d = experimental isotope 
pattern at a retention time of 14.27 min). 
 
Homopolymer P6  
Following the aforementioned procedure, P6 was obtained as a white solid (95 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.19–1.31 (m, 420 H, 210 CH2), 1.32–1.41 (m, 
286 H, 270 t-Bu, 8 CH2 end group), 1.51–1.64 (m, 60 H, 30 CH2CH2S), 1.72–1.88 (m, 
60 H, 30 CHCH2), 2.54 (t, J = 7.5 Hz, 60 H, 30 CH2S), 2.67–2.78 (m, 60 H, 30 SCH2), 
2.83–2.90 (m, 60 H, 30 CH2COO), 4.88–5.00 (m, 2 H, CH2 double bond), 5.05–5.22 
(m, 30 H, OCH(CO)), 5.90–6.01 (m, 1 H, CH double bond), 6.07 (s, 30 H, NH). 
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Figure 33: Mass spectra of homopolymer P6 with n repeating units and a calculated 
mass of 357.234 g/mol per repeating unit (a = retention time of 12.61 min, b = retention 
time of 11.79-14.73 min, c = calculated isotope pattern, d = experimental isotope 
pattern at a retention time of 12.61 min). 
 
Homopolymer P7  
Following the aforementioned procedure, P7 was obtained as a white solid (91 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.17–1.27 (m, 560 H, 280 CH2), 1.31–1.44 (m, 
376 H, 360 t-Bu, 8 CH2 end group), 1.50–1.62 (m, 80 H, 40 CH2CH2S), 1.76–1.89 (m, 
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80 H, 40 CHCH2), 2.55 (t, J = 7.4 Hz, 80 H, 40 CH2S), 2.66–2.76 (m, 80 H, 40 SCH2), 
2.83–2.95 (m, 80 H, 40 CH2COO), 4.88–5.01 (m, 2 H, CH2 double bond), 5.06–5.17 
(m, 40 H, OCH(CO)), 5.92–6.01 (m, 1 H, CH double bond), 6.11 (s, 40 H, NH). 
 
 
 
Figure 34: Mass spectra of homopolymer P7 with n repeating units and a calculated 
mass of 357.234 g/mol per repeating unit (a = retention time of 12.37 min, b = retention 
time of 11.76-14.39 min, c = calculated isotope pattern, d = experimental isotope 
pattern at a retention time of 12.37 min). 
 
5
6
0
.7
9
3
7
6
.1
8
8
2
.1
2
8
1
.1
4
8
0
.5
4
7
9
.8
5
8
0
.1
9
2
.0
7
4
0
.6
9
1
.0
3
4
0
.0
0
6. Experimental Part 
 
102 
Synthesis of copolymers P8 and P9 via Passerini reaction 
 
General procedure: To a vigorously stirred solution of homopolymer P1 (100 mg, 
0.0137 mmol) and benzyl isocyanide 8 (1.37 mmol, 0.685 mmol,) in 1.50 mL DCM, the 
AB-type monomer 3 (0.274 mmol, 0.137 mmol,) in 1.50 mol/L DCM was added slowly. 
After stirring for 24 hours at room temperature, the polymer was precipitated from 
diethyl ether. 
 
Copolymer P8 
Following the aforementioned procedure, P8 was obtained as sticky brown solid 
(87 %). 1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.14–1.29 (m, 560 H, 280 CH2), 1.31–
1.40 (m, 196 H, 180 t-Bu, 8 CH2 end group), 1.50–1.64 (m, 80 H, 40 CH2CH2S), 1.75–
1.93 (m, 80 H, 40 CHCH2), 2.28–2.34 (m, 40 H, 20 CH2S), 2.53 (t, J = 7.3 Hz, 40 H, 
20 CH2S), 2.63–2.65 (m, 80 H, 40 SCH2), 2.77–2.89 (m, 80 H, 40 CH2COO), 4.32–
4.52 (m, 40 H, 20 NCH2), 4.91–4.97 (m, 2 H, CH2 double bond), 5.03–5.11 (m, 20 H, 
OCH(CO)) 5.16–5.36 (m, 20 H, OCH(CO)), 5.78–5.85 (m, 1 H, CH double bond), 6.10 
(s, 20 H, NH), 6.95–7.07 (m, 20 H, NH), 7.11–7.23 (m, 40 H, 40 Ar-H), 7.29–7.41 (m, 
60 H, 60 Ar-H); Tg = 5 °C. 
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Copolymer P9 
Following the aforementioned procedure, P9 was obtained as sticky brown solid 
(88 %). 1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.14–1.29 (m, 420 H, 210 CH2), 1.31–
1.40 (m, 196 H, 180 t-Bu, 8 CH2 end group), 1.50–1.64 (m, 60 H, 30 CH2CH2S), 1.75–
1.93 (m, 60 H, 30 CHCH2), 2.28–2.34 (m, 20 H, 10 CH2S), 2.53 (t, J = 7.3 Hz, 40 H, 
20 CH2S), 2.63–2.65 (m, 60 H, 30 SCH2), 2.77–2.89 (m, 60 H, 30 CH2COO), 4.32–
4.52 (m, 20 H, 10 NCH2), 4.91–4.97 (m, 2 H, CH2 double bond), 5.03–5.11 (m, 20 H, 
OCH(CO)) 5.16–5.36 (m, 10 H, OCH(CO)), 5.78–5.85 (m, 1 H, CH double bond), 6.10 
(s, 20 H, NH), 6.95–7.07 (m, 10 H, NH), 7.11–7.23 (m, 20 H, 20 Ar-H), 7.29–7.41 (m, 
30 H, 30 Ar-H); Tg = 5 °C. 
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Synthesis of star-shaped homopolymer P10 via Passerini reaction 
 
To a vigorously stirred solution of trimesic acid 9 (5.12 mg, 0.024 mmol) and tert-butyl 
isocyanide 5 (606 mg, 7.30 mmol) in 0.5 mL THF, the AB-type monomer 3 (400 mg, 
1.46 mmol) in 0.5 mL DCM was added slowly. After stirring for 24 hours at room 
temperature, the polymer was precipitated from diethyl ether. 
Following the aforementioned procedure, P10 was obtained as white solid (93 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.22–1.30 (m, 840 H, 420 CH2), 1.32–1.36 (m, 
540 H, t-Bu), 1.53–1.61 (m, 120 H, 60 CH2CH2S), 1.75–1.87 (m, 120 H, 60 CHCH2), 
2.53 (t, J = 7.5 Hz, 120 H, 60 CH2S), 2.66–2.72 (m, 120 H, 60 SCH2), 2.77–2.85 (m, 
120 H, 60 CH2COO), 5.04–5.11 (m, 60 H, OCH(CO)), 6.06–6.16 (m, 60 H, NH), 8.89–
8.91 (m, 3 H, Ar-H); Tg = 6 °C. 
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Synthesis of star-shaped copolymer P11 via Passerini reaction 
 
To a vigorously stirred solution of star-shaped homopolymer P10 (100 mg, 
0.0046 mmol) and benzyl isocyanide 8 (162 mg, 1.38 mmol) in 0.1 mL DCM, the AB-
type monomer 3 (76 mg, 0.276 mmol) in 0.1 mL DCM was added slowly. After stirring 
for 24 hours at room temperature, the polymer was precipitated from diethyl ether. 
Following the aforementioned procedure, P11 was obtained as sticky brown solid 
(82 %). 1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.06–1.28 (m, 1320 H, 660 CH2), 1.32–
1.39 (m, 540 H, t-Bu), 1.48–1.64 (m, 180 H, 90 CH2CH2S), 1.72–1.91 (m, 180 H, 90 
CHCH2), 2.26–2.35 (m, 60 H, 30 CH2S), 2.52 (t, J = 7.4 Hz, 120 H, 60 CH2S), 2.63–
2.74 (m, 180 H, 60 SCH2), 2.76–2.85 (m, 180 H, 60 CH2COO), 4.31–4.50 (m, 60 H, 30 
NCH2), 5.01–5.09 (m, 60 H, OCH(CO)) 5.18–5.31 (m, 30 H, OCH(CO)), 6.11 (s, 60 H, 
NH), 6.98–7.09 (m, 30 H, NH), 7.17–7.25 (m, 60 H, 60 Ar-H), 7.27–7.35 (m, 90 H, 90 
Ar-H), 8.87–8.92 (m, 3 H, Ar-H); Tg = 8 °C. 
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Esterification with CDI to obtain star-shaped homopolymer P12[173] 
 
To a vigorously stirred solution of CDI 10 (32.4 mg, 0.20 mmol) in dry CH2Cl2 (0.60 mL), 
the star polymer P10 (average MW 21.8 kDa) (200 mg, 0.01 mmol) in dry CH2Cl2 
(0.90 mL) was added slowly under nitrogen. After stirring for 24 h at room temperature, 
the solution was precipitated in diethyl ether. 
Following the aforementioned procedure, P12 was obtained as white solid (90 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.16–1.29 (m, 840 H, 420 CH2), 1.31–1.36 (m, 
540 H, t-Bu), 1.53–1.59 (m, 120 H, 60 CH2CH2S), 1.74–1.86 (m, 120 H, 60 CHCH2), 
2.52 (t, J = 7.4 Hz, 120 H, 60 CH2S), 2.67–2.70 (m, 120 H, 60 SCH2), 2.76–2.84 (m, 
120 H, 60 CH2COO), 5.03–5.10 (m, 60 H, OCH(CO)), 6.06–6.13 (m, 60 H, NH), 7.09–
7.12 (m, 3 H, OCNCHCH), 7.46–7.49 (m, 3 H, OCNCH), 8.16–8.19 (m, 3 H, NCHN), 
8.88–8.91 (m, 3 H, Ar-H); Tg = 6 °C. 
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Figure 35: 1H NMR spectra of star-shaped homopolymer P10, star-shaped 
copolymer P11 and esterified star-shaped homopolymer P12. 
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6.4 Experimental procedures – chapter 4.2 
 
Synthesis of star-shaped homopolymers P13 and P14 via Passerini reaction 
 
General procedure: To a vigorously stirred solution of trimesic acid 9 (1.00 equiv.) and 
tert-butyl isocyanide 5 (75.0 equiv., 150 equiv.) in 1.50 mol/L THF, AB-type monomer 3 
(15.0 equiv., 30.0 equiv.) in 0.50 mL DCM was added slowly. After stirring for 24 hours 
at room temperature, the polymer was precipitated from ice-cold diethyl ether. 
 
Homopolymer P13 
Following the aforementioned procedure, P13 was obtained as white solid (93 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.22–1.30 (m, 420 H, 210 CH2), 1.32–1.36 (m, 
270 H, t-Bu), 1.53–1.61 (m, 60 H, 30 CH2CH2S), 1.75–1.87 (m, 60 H, 30 CHCH2), 2.53 
(t, J = 7.5 Hz, 60 H, 30 CH2S), 2.66–2.72 (m, 60 H, 30 SCH2), 2.77–2.85 (m, 60 H, 30 
CH2COO), 5.04–5.11 (m, 30 H, OCH(CO)), 6.06–6.16 (m, 30 H, NH), 8.89–8.91 (m, 3 
H, Ar-H). 
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Homopolymer P14 
Following the aforementioned procedure, P14 was obtained as white solid (95 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.20–1.33 (m, 210 H, 105 CH2), 1.31–1.36 (m, 
135 H, t-Bu), 1.55–1.64 (m, 30 H, 15 CH2CH2S), 1.71–1.83 (m, 30 H, 15 CHCH2), 2.53 
(t, J = 7.4 Hz, 30 H, 15 CH2S), 2.65–2.72 (m, 30 H, 15 SCH2), 2.77–2.86 (m, 30 H, 15 
CH2COO), 5.00–5.09 (m, 15 H, OCH(CO)), 6.05–6.16 (m, 15 H, NH), 8.88–8.91 (m, 3 
H, Ar-H). 
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Synthesis of PEG isocyanide 21 
11-Methoxy-11-oxoundecan-1-aminium chloride 15 
 
10.0 g 11-aminoundecanoic acid 13 (50.0 mmol, 1.00 equiv.) were suspended in 
75.0 mL methanol 14 (1.875 mol, 37.5 equiv.), which works as solvent and reactant. 
The suspension was cooled in an ice bath and subsequently 11.2 mL thionyl chloride 
(18.4 g, 0.155 mol, 3.10 equiv.) were added dropwise at 0 °C. After addition of thionyl 
chloride, the solution was warmed to room temperature and stirred overnight. The 
yellow solution was then poured into 350 mL diethyl ether and stored in the freezer 
overnight. The product was filtered off and dried under high vacuum. 11-(Methoxy)-11-
oxoundecan-1-aminium chloride 15 was obtained as a white solid (10.0 g, 80 %). 1H 
NMR (CD3OD, 300 MHz) δ (ppm) = 1.21–1.45 (m, 12 H, 6 CH2), 1.47–1.71 (m, 4 H, 2 
CH2), 2.30 (t, J = 7.4 Hz, 2 H, CH2), 2.90 (t, J = 7.5 Hz, 2 H, CH2), 3.56–3.63 (m, 3 H, 
CH3); 13C NMR (CD3OD, 75 MHz) δ (ppm): 26.0, 27.4, 28.5, 30.1, 30.2, 30.3, 30.4, 
30.4, 34.8, 40.8, 52.0, 176.0; FAB of [C12H26NO2]+ = 216.2; HRMS (FAB) of 
[C12H26NO2]+ calc. 216.1958, found 216.1956; IR (KBr) ν = 2918.6, 2848.1, 1722.4, 
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1561.0, 1510.4, 1467.9, 1443.6, 1375.6, 1334.0, 1306.1, 1276.8, 1245.0, 1210.6, 
1174.5, 1097.3, 1001.1, 970.7, 938.2, 885.7, 723.3, 425.6 cm-1. 
 
 
Methyl 11-formamidoundecanoate 17 
 
9.80 g 11-(methoxy)-11-oxoundecan-1-aminium chloride 15 (0.039 mol, 1.00 equiv.), 
were dissolved in 43.0 mL trimethyl orthoformate 16 (41.4 g, 0.39 mol, 10.0 eq.), which 
is used as solvent and reactant and heated to 100 °C for 12 hours. Trimethyl 
orthoformate was removed under reduced pressure and the product was used without 
further purification. Methyl 11-formamidoundecanoate 17 was obtained as a white solid 
(9.55 g, quant.). 1H NMR (CDCl3, 300 MHz) δ (ppm) = 1.16–1.40 (m, 12 H, 6 CH2), 
1.42–1.70 (m, 4 H, 2 CH2), 2.28 (t, J = 7.5 Hz, 2 H, CH2), 3.16–3.35 (m, 2 H, CH2), 
3.66 (s, 3 H, CH3), 5.71 (s, 1 H, NH), 8.01–8.28 (m, 1 H, OCH); 13C NMR (CDCl3, 75 
MHz) δ (ppm): 25.0, 26.5, 26.9, 29.2, 29.3, 29.4, 29.5, 29.6, 34.2, 38.3, 51.6, 161.3, 
174.5; FAB of [C13H26NO3]+ = 244.2; HRMS (FAB) of [C13H26NO3]+ calc. 244.1907, 
found 244.1906; IR (KBr) ν = 3255.9, 2914.8, 2848.0, 1734.9, 1682.5, 1637.3, 1534.4, 
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1462.8, 1435.5, 1378.3, 1334.1, 1300.6, 1268.2, 1226.0, 1203.7, 1168.0, 1113.0, 
1070.0, 1002.0, 980.5, 883.3, 720.7, 518.7, 449.4, 380.1 cm-1. 
 
 
Methyl 11-isocyanoundecanoate 19 
 
9.55 g methyl 11-formamidoundecanoate 17 (0.039 mol, 1.00 equiv.) were dissolved 
in 120 mL dichloromethane (0.33 M), 17.2 mL diisopropylamine 18 (12.4 g, 0.122 mol, 
3.10 equiv.) were added and the reaction mixture was cooled to 0 °C. Subsequently, 
4.77 mL phosphorous oxy chloride (7.82 g, 0.051 mmol, 1.30 equiv.) were added 
dropwise and the reaction mixture was stirred at room temperature for two hours. The 
reaction was quenched by adding sodium carbonate solution (20 %, 75.0 mL) at 0 °C. 
After stirring this mixture for 30 minutes, 50.0 mL water and 50.0 mL dichloromethane 
were added. The aqueous phase was separated and the organic layer was washed 
with brine (4 x 80.0 mL). The combined organic layers were dried over sodium sulfate 
and the solvent was evaporated under reduced pressure. The crude product was then 
purified by column chromatography (n-hexane / ethyl acetate 19:1 – 8:1). Methyl 11-
isocyanoundecanoate 19 was obtained as slightly yellow oil (4.30 g, 52 %). Rf = 0.49 
(n-hexane/ethyl acetate = 5:1); 1H NMR (CDCl3, 300 MHz) δ (ppm) = 1.18–1.50 (m, 12 
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H, 6 CH2), 1.52–1.75 (m, 4 H, 2 CH2), 2.29 (t, J = 7.5 Hz, 2 H, CH2), 3.30–3.43 (m, 2 
H, CH2), 3.66 (s, 3 H, CH3); 13C NMR (CDCl3, 75 MHz) δ (ppm): 24.9, 26.3, 28.6, 29.1, 
29.1, 29.2, 34.0, 41.4, 41.5, 41.5, 51.4, 155.7, 174.2; FAB of [C13H22NO2]- = 224.2; 
HRMS (FAB) of [C13H22NO2]- calc. 224.1645, found 224.1644; IR (KBr) ν = 2925.0, 
2854.2, 2146.0 (isocyanide), 1735.0, 1435.6, 1352.7, 1194.4, 1169.1, 1103.9, 1010.8, 
850.2, 722.1 cm-1. 
 
 
PEG isocyanide 21 
 
3.00 g poly(ethylene glycol) methyl ether 20 (4.00 mmol, 1.00 equiv., 750 g/mol) and 
4.50 g methyl 11-isocyanoundecanoate 21 (20.0 mmol, 5.00 equiv.) were placed and 
28.0 mg TBD (0.20 mmol, 5.00 mol%) were added and the reaction mixture was 
distilled at 100 °C for 3 days (a continuous air flow was bubbled through the solution 
to remove the resulting methanol from the reaction mixture). Afterwards, the polymer 
was precipitated from ice-cold diethyl ether to obtain a yellow solid (1.85 g, 50 %). 
1H NMR (CDCl3, 300 MHz) δ (ppm) = 1.19–1.47 (m, 12 H, 6 CH2), 1.49–1.71 (m, 4 H, 
2 CH2), 2.29 (t, J = 7,5 Hz, 2 H, CH2), 3.27–3.41 (m, 5 H, CH2, CH3), 3.49–3.67 (m, 66 
H, 33 PEG-CH2), 4.18 (t, J = 4,8 Hz, 2 H, OCOCH2). 
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0
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Synthesis of PEG aldehyde 23 
 
316 mg 10-undecenal 1 (1.875 mmol, 2.00 equiv.) and 12.0 mg DMPA (0.047 mmol, 
5.00 mol%) were placed in a quartz tube and dissolved in 0.50 mL THF. Then, the tube 
was purged with argon for 10 min and afterwards the solution was exposed to UV light 
(365 nm) for 30 s. Subsequently, 750 mg PEG thiol 22 (0.9375 mmol, 1.00 equiv., 
800 g/mol) dissolved in 0.40 mL THF were added. The reaction mixture was stirred for 
24 h under UV irradiation. Afterwards, the product was precipitated from ice-cold 
diethyl ether to obtain a white solid (610 mg, 70 %). 1H NMR (CDCl3, 300 MHz) δ (ppm) 
= 1.17–1.41 (m, 12 H, 6 CH2), 1.47–1.68 (m, 4 H, 2 CH2), 2.34–2.46 (m, 2 H, CH2), 
2.47–2.58 (m, 2 H, CH2), 2.63–2.78 (m, 2 H, CH2), 3.37 (s, 3 H, CH3), 3.48–3.57 (m, 2 
H, CH2), 3.58–3.71 (m, 60 H, 30 PEG-CH2), 9.75 (s, 1 H, OCH). 
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Synthesis of functionalized star-shaped polymers 
Star-shaped polymer P15, P16 and P17 (10 repeating units, 1 PEG 2000 g/mol) 
using different isocyanides 
 
General procedure: To a vigorously stirred solution of star-shaped polymer P13 
(1.00 equiv.) and PEG aldehyde (2000 g/mol) 12 (3.00 equiv.) in 0.05 mol/L DCM, tert-
butyl isocyanide 5, benzyl isocyanide 8 or tert-butyl 2-isocyanoacetate 11 (15.0 equiv.) 
were added slowly. After stirring for 72 hours at room temperature, the polymer was 
precipitated from diethyl ether. 
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Following the aforementioned procedure, P15 was obtained as white solid (94 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.12–1.31 (m, 420 H, 210 CH2), 1.32–1.41 (m, 
297 H, t-Bu), 1.46–1.66 (m, 72 H, 30 CH2CH2S, 3 CH2CH2CONH, 3 CH2CH2CHO), 
1.72–1.90 (m, 60 H, 30 CHCH2), 1.93–2.01 (m, 6 H, 3 CH2CONH), 2.13–2.21 (m, 6 H, 
3 CH2COO), 2.53 (t, J = 7.4 Hz, 60 H, 30 CH2S), 2.65–2.75 (m, 60 H, 30 SCH2), 2.77–
2.86 (m, 60 H, 30 CH2COO), 3.36 (s, 3 H, CH3), 3.46–3.50 (m, 12 H, 3 OCH2, 3 
NHCH2), 3.59–3.69 (m, 492 H, 246 PEG-CH2), 5.03–5.25 (m, 33 H, OCH(CO)), 5.81–
6.10 (m, 33 H, NH), 8.88–8.92 (m, 3 H, Ar-H). 
 
 
Following the aforementioned procedure, P16 was obtained as yellow solid (89 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.17–1.30 (m, 420 H, 210 CH2), 1.31–1.36 (m, 
270 H, t-Bu), 1.47–1.67 (m, 72 H, 30 CH2CH2S, 3 CH2CH2CONH, 3 CH2CH2CHO), 
1.68–1.90 (m, 60 H, 30 CHCH2), 1.92–2.01 (m, 6 H, 3 CH2CONH), 2.10–2.23 (m, 6 H, 
3 CH2COO), 2.53 (t, J = 7.4 Hz, 60 H, 30 CH2S), 2.65–2.75 (m, 60 H, 30 SCH2), 2.76–
2.88 (m, 60 H, 30 CH2COO), 3.37 (s, 3 H, CH3), 3.45–3.49 (m, 12 H, 3 OCH2, 3 
NHCH2), 3.58–2.68 (m, 492 H, 246 PEG-CH2), 5.03–5.26 (m, 33 H, OCH(CO)), 5.80–
6.13 (m, 33 H, NH), 7.21–7.43 (m, 15 H, Arbenzyl-H), 8.88–8.92 (m, 3 H, Ar-H). 
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Following the aforementioned procedure, P17 was obtained as yellow solid (91 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.17–1.31 (m, 420 H, 210 CH2), 1.32–1.37 (m, 
297 H, t-Bu), 1.53–1.64 (m, 72 H, 30 CH2CH2S, 3 CH2CH2CONH, 3 CH2CH2CHO), 
1.74–1.90 (m, 60 H, 30 CHCH2), 1.92–2.04 (m, 12 H, 3 CH2CONH, 3 NHCH2CO), 
2.14–2.22 (m, 6 H, 3 CH2COO), 2.54 (t, J = 7.4 Hz, 60 H, 30 CH2S), 2.66–2.74 (m, 60 
H, 30 SCH2), 2.78–2.87 (m, 60 H, 30 CH2COO), 3.38 (s, 3 H, CH3), 3.45–3.51 (m, 12 
H, 3 OCH2, 3 NHCH2), 3.56–3.73 (m, 492 H, 246 PEG-CH2), 5.04–5.23 (m, 33 H, 
OCH(CO)), 5.82–6.14 (m, 33 H, NH), 8.89–8.92 (m, 3 H, Ar-H). 
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Star-shaped polymer P18 (5 repeating units, 1 PEG 2000 g/mol)  
 
General procedure: To a vigorously stirred solution of star-shaped polymer P14 
(1.00 equiv.) and PEG aldehyde (2000 g/mol) 12 (3.00 equiv.) in 0.05 mol/l DCM, tert-
butyl isocyanide 5 (15.0 equiv.) was added slowly. After stirring for 72 hours at room 
temperature, the polymer was precipitated from diethyl ether. 
 
Following the aforementioned procedure, P14 was obtained as white solid (85 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.17–1.31 (m, 210 H, 105 CH2), 1.32–1.41 (m, 
162 H, t-Bu), 1.49–1.66 (m, 42 H, 15 CH2CH2S, 3 CH2CH2CONH, 3 CH2CH2CHO), 
1.72–1.88 (m, 30 H, 15 CHCH2), 1.93–2.00 (m, 6 H, 3 CH2CONH), 2.12–2.21 (m, 6 H, 
3 CH2COO), 2.52 (t, J = 7.4 Hz, 30 H, 15 CH2S), 2.63–2.74 (m, 30 H, 15 SCH2), 2.76–
2.85 (m, 30 H, 15 CH2COO), 3.37 (s, 3 H, CH3), 3.50–3.56 (m, 12 H, 3 OCH2, 3 
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NHCH2), 3.58–3.68 (m, 492 H, 246 PEG-CH2), 5.02–5.23 (m, 18 H, OCH(CO)), 5.78–
6.13 (m, 18 H, NH), 8.87–8.92 (m, 3 H, Ar-H). 
 
 
Figure 36: DLS results of functionalized star-shaped polymer P18 (5 repeating units 
and 1 PEG (2000 g/mol)): first row 1 mg/mL of P18, second row 0.1 mg/mL of P18, left 
in water with acetone (wA), middle in water without acetone (woA), right in 
dichloromethane (DCM). 
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Star-shaped polymer P19 (5 repeating units, 1 PEG 950 g/mol)  
 
General procedure: To a vigorously stirred solution of star-shaped polymer P14 
(1.00 equiv.) and PEG aldehyde (950 g/mol) 23 (3.00 equiv.) in 0.05 mol/l DCM, tert-
butyl isocyanide 5 (15.0 equiv.) was added slowly. After stirring for 72 hours at room 
temperature, the polymer was precipitated from diethyl ether. 
 
Following the aforementioned procedure, P19 was obtained as white solid (74 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.14–1.31 (m, 252 H, 126 CH2), 1.32–1.40 (m, 
162 H, t-Bu), 1.48–1.61 (m, 36 H, 18 CH2CH2S), 1.68–1.90 (m, 36 H, 18 CHCH2), 2.52 
(t, J = 7.4 Hz, 36 H, 18 CH2S), 2.63–2.74 (m, 36 H, 18 SCH2), 2.76–2.88 (m, 36 H, 15 
CH2COO, 3 CH2O), 3.37 (s, 3 H, CH3), 3.59–3.70 (m, 180 H, 90 PEG-CH2), 5.02–5.23 
(m, 18 H, OCH(CO)), 5.78–6.13 (m, 18 H, NH), 8.88–8.91 (m, 3 H, Ar-H). 
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Figure 37: DLS results of functionalized star-shaped polymer P19 (5 repeating units 
and 1 PEG (950 g/mol)): first row 1 mg/mL of P19, second row 0.1 mg/mL of P19, left 
in water with acetone (wA), middle in water without acetone (woA), right in 
dichloromethane (DCM). 
 
Star-shaped polymer P20 (5 repeating units, 2 PEG a 950 g/mol)  
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General procedure: Star-shaped polymer P14 (1.00 equiv.), PEG aldehyde 
(950 g/mol) 23 (3.00 equiv.) and PEG isocyanide (950 g/mol) 21 (3.00 equiv.) were 
dissolved in 0.05 mol/l DCM. After 24 hours at room temperature PEG aldehyde 
(950 g/mol) 23 (3.00 equiv.) and PEG isocyanide (950 g/mol) 21 (3.00 equiv.) were 
added again and precipitated from diethyl ether after 72 hours. 
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Following the aforementioned procedure, P20 was obtained as slightly yellow solid 
(78 %). 1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.16–1.29 (m, 300 H, 150 CH2), 1.30–
1.42 (m, 135 H, t-Bu), 1.46–1.66 (m, 36 H, 18 CH2CH2S), 1.67–1.90 (m, 36 H, 18 
CHCH2), 2.27–2.32 (m, 6 H, 3 CH2COO), 2.51 (t, J = 7.4 Hz, 36 H, 18 CH2S), 2.60–
2.73 (m, 36 H, 18 SCH2), 2.74–2.86 (m, 36 H, 15 CH2COO, 3 CH2O), 3.35 (s, 3 H, 
CH3), 3.54–3.77 (m, 378 H, 189 PEG-CH2), 4.13–4.24 (m, 6 H, 3 NHCH2), 4.97–5.26 
(m, 18 H, OCH(CO)), 5.75–6.16 (m, 18 H, NH), 8.83–8.92 (m, 3 H, Ar-H). 
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Figure 38: DLS results of functionalized star-shaped polymer P20 (5 repeating units 
and 2 PEG (950 g/mol)): first row 1 mg/mL of P20, second row 0.1 mg/mL of P20, left 
in water with acetone (wA), middle in water without acetone (woA), right in 
dichloromethane (DCM). 
 
Star-shaped polymer P21 (10 repeating units, 2 PEG a 950 g/mol)  
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General procedure: Star-shaped polymer P13 (1.00 equiv.), PEG aldehyde 
(950 g/mol) 23 (3.00 equiv.) and PEG isocyanide (950 g/mol) 21 (3.00 equiv.) were 
dissolved in 0.05 mol/l DCM. After 24 hours at room temperature PEG aldehyde 
(950 g/mol) 23 (3.00 equiv.) and PEG isocyanide (950 g/mol) 21 (3.00 equiv.) were 
added again and precipitated from diethyl ether after 72 hours. 
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Following the aforementioned procedure, P21 was obtained as slightly yellow solid 
(80 %). 1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.17–1.30 (m, 510 H, 255 CH2), 1.31–
1.41 (m, 270 H, t-Bu), 1.47–1.66 (m, 66 H, 33 CH2CH2S), 1.74–1.93 (m, 66 H, 33 
CHCH2), 2.24–2.36 (m, 6 H, 3 CH2COO), 2.52 (t, J = 7.4 Hz, 66 H, 33 CH2S), 2.63–
2.73 (m, 66 H, 33 SCH2), 2.74–2.85 (m, 66 H, 30 CH2COO, 3 CH2O), 3.36 (s, 3 H, 
CH3), 3.58–3.66 (m, 378 H, 189 PEG-CH2), 4.14–4.24 (m, 6 H, 3 NHCH2), 5.01–5.26 
(m, 18 H, OCH(CO)), 5.78–6.16 (m, 18 H, NH), 8.88–8.92 (m, 3 H, Ar-H). 
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Figure 39: DLS results of functionalized star-shaped polymer P21 (10 repeating units 
and 2 PEG (950 g/mol)): first row 1 mg/mL of P21, second row 0.1 mg/mL of P21, left 
in water with acetone (wA), middle in water without acetone (woA), right in 
dichloromethane (DCM). 
 
 
Figure 40: Pictures of the encapsulation of water-insoluble para red in water of four 
different polymers (from the left side to the right side: P19, P21, P18 and P20). 
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Figure 41: Pictures of the encapsulation and the phase transfer of Orange II from water 
(top phase) to dichloromethane (bottom phase) of four different polymers (from the left 
side to the right side: P20, P19, P18 and P21). 
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6.5 Experimental procedures – chapter 4.3 
 
Star-shaped homopolymer P22 
 
General procedure: To a vigorously stirred solution of trimesic acid 9 (1.00 equiv.) and 
methyl isocyanoacetate 24 (75.0 equiv.) in 1.50 mol/L THF, AB-type monomer 3 
(15.0 equiv.) in 0.50 mL DCM was added slowly. After stirring for 24 hours at room 
temperature, the polymer was precipitated from ice-cold diethyl ether. 
Following the aforementioned procedure, P22 was obtained as yellow solid (89 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.20–1.41 (m, 210 H, 105 CH2), 1.52–1.64 (m, 
30 H, 15 CH2CH2S), 1.81–2.07 (m, 30 H, 15 CHCH2), 2.46–2.58 (m, 30 H, 15 CH2S), 
2.67–2.77 (m, 30 H, 15 SCH2), 2.79–2.89 (m, 30 H, 15 CH2COO), 3.75 (s, 45 H, 15 
OCH3), 3.90–4.17 (m, 30 H, 15 NHCH2), 5.24–5.46 (m, 15 H, OCH(CO)), 6.79–7.06 
(m, 15 H, NH), 8.87–9.01 (m, 3 H, Ar-H). 
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Star-shaped copolymer P23 
5
m
 
General procedure: Star-shaped polymer P22 (1.00 equiv.), PEG aldehyde 
(950 g/mol) 23 (3.00 equiv.) and PEG isocyanide (950 g/mol) 21 (3.00 equiv.) were 
dissolved in 0.05 mol/l DCM. After 24 hours at room temperature PEG aldehyde 
(950 g/mol) 23 (3.00 equiv.) and PEG isocyanide (950 g/mol) 21 (3.00 equiv.) were 
added again and precipitated from diethyl ether after 72 hours. 
 
Following the aforementioned procedure, P22 was obtained as yellow solid (72 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.17–1.41 (m, 300 H, 150 CH2), 1.50–1.57 (m, 
36 H, 18 CH2CH2S), 1.76–1.92 (m, 36 H, 18 CHCH2), 2.26–2.35 (m, 6 H, 3 CH2COO), 
2.47–2.58 (m, 36 H, 18 CH2S), 2.66–2.76 (m, 36 H, 18 SCH2), 2.78–2.88 (m, 36 H, 15 
CH2COO, 3 CH2O), 3.36 (s, 18 H, CH3), 3.59–3.67 (m, 378 H, 189 PEG-CH2), 3.74 (s, 
45 H, OCH3), 3.95–4.24 (m, 36 H, 15 NHCH2, 3 NHCH2), 5.15–5.44 (m, 18 H, 
OCH(CO)), 6.53–6.93 (m, 18 H, NH), 8.92–8.96 (m, 3 H, Ar-H). 
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Oxidized star-shaped copolymers P24 and P25 
 
General procedure: Star-shaped copolymer P20 or P23 (1.00 equiv.) was dissolved in 
35 mL dichloromethane and afterwards 3-chloroperbenzoic acid (6.0 eq. with respect 
to the sulfur atom) was added. The reaction mixture was stirred at room temperature 
for 2 days. By the addition of saturated sodium sulfite solution, remaining oxidizing 
agent was quenched. Subsequently, the organic layer was separated and the aqueous 
layer was extracted with DCM (two times). To obtain the oxidized star-shaped 
copolymer P24 or P25, the combined organic layers were washed with 1 M sodium 
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hydroxide solution, dried over sodium sulfate and the solvent was evaporated under 
reduced pressure. 
Alternative procedure: Star-shaped copolymer P20 or P23 (100 mg, 1.00 equiv.) was 
dissolved in THF (5.0 mL) and hydrogen peroxide (30%, 2.0 mL) was added. After 
stirring the mixture for 1 day at 60 °C, additional hydrogen peroxide (30%, 2.0 mL) was 
added and the mixture was stirred for one more day. Afterwards, the reaction mixture 
was cooled down to room temperature and the oxidized polymer was precipitated into 
cold diethyl ether. The crude polymer was dissolved in DCM and washed with water. 
Subsequently, the organic layers were dried over sodium sulfate, filtered and 
evaporated under reduced pressure to obtain the oxidized star-shaped copolymer P24 
or P25. 
 
Following the general procedure, P24 was obtained as slightly yellow solid (89 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.18–1.33 (m, 300 H, 150 CH2), 1.35–1.40 (m, 
135 H, t-Bu), 1.52–1.67 (m, 36 H, 18 CH2CH2S), 1.74–1.88 (m, 36 H, 18 CHCH2), 
2.27–2.36 (m, 6 H, 3 CH2COO), 2.81–3.35 (m, 108 H, 18 CH2S, 18 SCH2, 15 CH2COO, 
3 CH2O), 3.37 (s, 18 H, CH3), 3.58–3.68 (m, 378 H, 189 PEG-CH2), 4.18–4.25 (m, 6 
H, 3 NHCH2), 4.99–5.25 (m, 18 H, OCH(CO)), 5.80–6.11 (m, 18 H, NH), 8.88–8.93 (m, 
3 H, Ar-H). 
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Following the general procedure, P25 was obtained as yellow solid (81 %). 1H NMR 
(CDCl3, 300 MHz): δ (ppm) = 1.20–1.38 (m, 300 H, 150 CH2), 1.40–1.53 (m, 36 H, 18 
CH2CH2S), 1.77–1.87 (m, 36 H, 18 CHCH2), 2.26–2.34 (m, 6 H, 3 CH2COO), 2.75–
3.35 (m, 108 H, 18 CH2S, 18 SCH2, 15 CH2COO, 3 CH2O), 3.37 (s, 18 H, CH3), 3.57–
3.70 (m, 378 H, 189 PEG-CH2), 3.73 (s, 45 H, OCH3), 3.88–4.22 (m, 36 H, 15 NHCH2, 
3 NHCH2), 5.11–5.48 (m, 18 H, OCH(CO)), 6.46–7.11 (m, 18 H, NH), 8.90–8.97 (m, 3 
H, Ar-H). 
 
 
Synthesis of four-armed star-shaped polymers via Passerini reaction 
Four-armed star-shaped homopolymers P26, P27, P28 and P29  
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General procedure: To a vigorously stirred solution of 3,3,5,5-
tetracarboxydiphenylmethane 25 (1.00 equiv.) and tert-butyl isocyanide 5 (20.0 equiv., 
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40 equiv., 80.0 equiv., 120 equiv.) in 1.50 mol/L THF, AB-type monomer 3 (100 equiv., 
200 equiv., 400 equiv., 600 equiv.) was added slowly. After stirring for 48 hours at room 
temperature, the polymers were precipitated from ice-cold diethyl ether to obtain four-
armed star-shaped homopolymers P26, P27, P28, and P29. 
 
Following the aforementioned procedure, P26 (5 repeating units) was obtained as 
yellow solid (60 %). 1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.22–1.28 (m, 280 H, 140 
CH2), 1.32–1.36 (m, 180 H, t-Bu), 1.49–1.68 (m, 40 H, 20 CH2CH2S), 1.69–1.99 (m, 
40 H, 20 CHCH2), 2.53 (t, J = 7.4 Hz, 40 H, 20 CH2S), 2.58–2.73 (m, 40 H, 20 SCH2), 
2.74–2.89 (m, 40 H, 20 CH2COO), 4,20–4,26 (m, 2 H, CH2-Ar), 5.03–5.26 (m, 20 H, 
OCH(CO)), 5.80–6.20 (m, 20 H, NH), 8.03–8.14 (m, 4 H, Ar-H), 8.54–8.60 (m, 2 H, Ar-
H). 
 
 
Following the aforementioned procedure, P27 (10 repeating units) was obtained as 
yellow solid (31 %). 1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.16–1.31 (m, 560 H, 280 
CH2), 1.32–1.46 (m, 360 H, t-Bu), 1.49–1.69 (m, 80 H, 40 CH2CH2S), 1.70–2.00 (m, 
80 H, 40 CHCH2), 2.53 (t, J = 7.4 Hz, 80 H, 40 CH2S), 2.58–2.72 (m, 80 H, 40 SCH2), 
2.73–2.89 (m, 80 H, 40 CH2COO), 4,21–4,25 (m, 2 H, CH2-Ar), 5.01–5.26 (m, 40 H, 
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OCH(CO)), 5.79–6.26 (m, 40 H, NH), 8.03–8.12 (m, 4 H, Ar-H), 8.54–8.61 (m, 2 H, Ar-
H). 
 
 
Following the aforementioned procedure, P28 (20 repeating units) was obtained as 
yellow solid (50 %). 1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.16–1.31 (m, 1120 H, 560 
CH2), 1.32–1.49 (m, 720 H, t-Bu), 1.50–1.68 (m, 160 H, 80 CH2CH2S), 1.69–2.00 (m, 
160 H, 80 CHCH2), 2.53 (t, J = 7.4 Hz, 160 H, 80 CH2S), 2.58–2.73 (m, 160 H, 80 
SCH2), 2.74–2.89 (m, 160 H, 80 CH2COO), 4.22–4.26 (m, 2 H, CH2-Ar), 5.00–5.25 (m, 
80 H, OCH(CO)), 5.80–6.25 (m, 80 H, NH), 8.08–8.13 (m, 4 H, Ar-H), 8.53–8.62 (m, 2 
H, Ar-H). 
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Following the aforementioned procedure, P29 (30 repeating units) was obtained as 
yellow solid (33 %). 1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.15–1.31 (m, 1680 H, 840 
CH2), 1.32–1.46 (m, 1080 H, t-Bu), 1.49–1.67 (m, 240 H, 120 CH2CH2S), 1.68–1.92 
(m, 240 H, 120 CHCH2), 2.53 (t, J = 7.4 Hz, 240 H, 120 CH2S), 2.58–2.73 (m, 240 H, 
120 SCH2), 2.74–2.89 (m, 240 H, 120 CH2COO), 4,21–4,26 (m, 2 H, CH2-Ar), 5.04–
5.22 (m, 120 H, OCH(CO)), 5.80–6.18 (m, 120 H, NH), 8.07–8.12 (m, 4 H, Ar-H), 8.53–
8.58 (m, 2 H, Ar-H). 
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Four-armed star-shaped homopolymer P30 
 
General procedure: To a vigorously stirred solution of 3,3,5,5-
tetracarboxydiphenylmethane 25 (1.00 equiv.) and methyl isocyanoacetate 24 
(50.0 equiv.) in 1.50 mol/L THF, AB-type monomer 3 (20.0 equiv.) was added slowly. 
After stirring for 48 hours at room temperature, the polymer was precipitated from ice-
cold diethyl ether. 
Following the aforementioned procedure, P30 was obtained as yellow solid (58 %). 
1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.10–1.47 (m, 280 H, 140 CH2), 1.49–1.67 (m, 
40 H, 20 CH2CH2S), 1.75–2.06 (m, 40 H, 20 CHCH2), 2.45–2.58 (m, 40 H, 20 CH2S), 
2.59–2.76 (m, 40 H, 20 SCH2), 2.77–2.95 (m, 30 H, 15 CH2COO), 3.72–3.80 (m, 60 H, 
15 OCH3), 3.91–4.16 (m, 40 H, 20 NHCH2), 4.24–4.28 (m, 2 H, CH2-Ar), 5.18–5.49 (m, 
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20 H, OCH(CO)), 6.65–7.16 (m, 20 H, NH), 8.11–8.27 (m, 4 H, Ar-H), 8.57–8.68 (m, 2 
H, Ar-H). 
 
 
Four-armed star-shaped copolymer P31 
 
General procedure: Star-shaped polymer P26 (1.00 equiv.), PEG aldehyde 
(950 g/mol) 23 (4.00 equiv.) and PEG isocyanide (950 g/mol) 21 (4.00 equiv.) were 
dissolved in 0.05 mol/l DCM. After 24 hours at room temperature PEG aldehyde 
(950 g/mol) 23 (4.00 equiv.) and PEG isocyanide (950 g/mol) 21 (4.00 equiv.) were 
added again and precipitated from diethyl ether after 72 hours. 
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Following the aforementioned procedure, P31 was obtained as slightly yellow solid 
(82 %). 1H NMR (CDCl3, 300 MHz): δ (ppm) = 1.16–1.30 (m, 408 H, 204 CH2), 1.31–
1.42 (m, 180 H, t-Bu), 1.47–1.66 (m, 48 H, 24 CH2CH2S), 1.70–1.95 (m, 48 H, 24 
CHCH2), 2.28–2.35 (m, 8 H, 4 CH2COO), 2.49–2.57 (m, 48 H, 24 CH2S), 2.65–2.75 
(m, 48 H, 24 SCH2), 2.76–2.86 (m, 48 H, 24 CH2COO), 3.37 (s, 24 H, CH3), 3.61–3.67 
(m, 504 H, 252 PEG-CH2), 4.18–4.26 (m, 10 H, 4 NHCH2, ArCH2), 5.03–5.23 (m, 24 
H, OCH(CO)), 5.76–6.17 (m, 24 H, NH), 8.08–8.12 (m, 4 H, Ar-H), 8.54–8.58 (m, 2 H, 
Ar-H). 
 
 
Drug loading and Encapsulation Efficiency 
A 100 mg/mL solution of star-shaped block copolymers in THF was mixed with a 
100 mg/mL solution of Azithromycin in THF - molecular ratio of 1:10 - and introduced 
into 10 volumes of deionized water under vigorous stirring. The organic solvent was 
removed using a rotary evaporator and the solution was centrifuged for 5 min at 
14000 rpm. The supernatant containing the Azithromycin loaded star-shaped block 
copolymers micelles was removed and freeze dried, whereas the unloaded water-
insoluble Azithromycin was collected, solubilized in a ACN/water solution (1:1) and 
quantified by UV/VIS spectrophotometry at 210 nm referring to a standard calibration 
curve (Figure 42). Therefore, a 5.00 mg/mL Azithromycin solution in ACN/water (1:1) 
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was prepared and diluted with ACN/water (1:1) solution. The absorbance was 
measured in triplicate at 210 nm by UV/VIS spectrophotometry. 
 
 
Figure 42: Azithromycin standard calibration curve. 
 
The total amount of drug was determined by simultaneously preparing a polymer-free 
sample with an equal content of Azithromycin. The amount of loaded drug was 
calculated by taking the difference between both samples. 
 
In Vitro Drug Release Study 
Drug release studies were performed in phosphate-buffered saline (PBS with 0.10 % 
Tween 20) at pH 7.4 (blood pH)[203] and citrate phosphate buffer (0.10 M citric acid, 
0.20 M Na2HPO4 and 0.10 % Tween 20) 204  at pH 5.0 (lysosome pH). A sample 
(5.00 mg) of Azithromycin-loaded and freeze-dried P31 micelles were dispersed in 
0.50 mL of release media and the solution was placed in a dialysis device (Slide-A-
LyzerTM mini dialysis device, 3.5 K MWCO, Thermo Scientific). The micellar solution 
was dialyzed against 1.50 mL of release media at 37 °C and samples (0.20 mL) were 
taken at appropriate time points and replaced with 0.20 mL fresh medium.[205] The 
collected samples were diluted with the same volume of ACN and the released 
Azithromycin was quantified by UV-Vis spectrophotometry at 210 nm referring to a 
standard calibration curve (Figure 42). The cumulative release (%) was defined based 
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on the concentration of Azithromycin calculated in the samples collected at different 
time points and considering the initial amount of encapsulated drug into the micelles. 
 
The following parts of this section were performed from Alessandra Travanut at the 
University of Nottingham in the working group of Alexander Cameron. 
 
Cell Culture 
The THP-1 (a human monocytic cell line) were cultured in RPMI 1640 media 
supplemented with 10 % fetal bovine serum, 5 % penicillin/streptomycin and 5 % L-
glutamine. To differentiate the monocytes to macrophages, cells were treated with 
50 ng/mL of PMA, which is dissolved in the medium, for 24 h at 37 °C, 5 % CO2.[206] 
Cells were differentiated at 0.1, 0.3, 0.5, 0.75, and 1 × 106 THP-1 cells/mL/ well in 96-
well tissue cultured-treated polystyrene plates (Corning Life Sciences). After 24 h, cells 
were washed with fresh media and incubated for 72 h at 37 °C, 5 % CO2 with 0.09 mL 
of media and 0.01 mL of PBS. Then, cells were washed with fresh media and 0.1 mL 
of fresh media and 0.10 mL of CellTiter-Fluor Cell Viability Assay solution were added. 
After 90 min of incubation at 37 °C, 5 % CO2, the fluorescence was measured with 
Tecan Spark 10M (400nmEm/505nmEx). The background fluorescence was determined 
by setting up triplicate wells without cells. The positive control was set up in triplicate 
wells containing cells 0.75 × 106 THP-1 cells/mL/well treated with 0.10 mL of 4 % 
paraformaldehyde in PBS. 
 
Viability Assay 
CellTiter-FluorTM cell viability Assay was performed to determine the cytotoxicity[207] of 
P31 against macrophage differentiated cells following the protocol provided by the 
vendor (Promega, Madison WI). Cells were treated for 72 h with different 
concentrations of P31. 
The THP-1 cells were cultured and differentiated (0.75 × 106 THP-1 cells/mL/well in 
96-well plate) as previously mentioned. After 24 h, cells were washed with fresh media 
and incubated for 72 h at 37 °C, 5 % CO2 with 0.09 mL of media and 0.01 mL of 
different concentrations of P31 in PBS (1.00, 5.00, 8.00 and 10.0 mg/mL - sterilized 
under 254 nm UV light for 30 minutes). Then, cells were washed with fresh media and 
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0.10 mL of fresh media and 0.10 mL of CellTiter-Fluor Cell Viability Assay solution 
were added. After 90 min of incubation at 37 °C, 5 % CO2, the fluorescence was 
measured with Tecan Spark 10M (400nmEm/505nmEx). The background fluorescence 
was determined by setting up triplicate wells without cells. The untreated control was 
set up in triplicate with untreated cells and 10 % of PBS. The positive control was set 
up in triplicate wells containing cells 0.75 x106 THP-1 cells/mL/well treated with 
0.10 mL of 4 % paraformaldehyde in PBS. 1.00 mg/mL solution of P31 in media was 
tested in triplicate wells without cells to test for possible interference with the assay 
chemistry. The protease activity was obtained using the following equation: 
 
G.2;93A9	H@;5I5;J = 	 KLFA3?C19 − KLFM3@)0.2/64KLF/6;.93;94	@26;.21 − KLFM3@)0.2/64 
 
Bacterial susceptibility assay 
To evaluate the bacteriostatic activity of Azithromycin-loaded unimolecular micelles 
P31, free or encapsulated Azithromycin was tested at drug concentrations of 0.10, 
1.00, 10.0 and 100 µg/mL against Staphyloccocus aureus SH1000 cultures. Bacteria 
were grown overnight in tryptic soy broth (TSB Difco). The next day, the optical density 
(OD600) of the culture was adjusted to 0.01 in fresh TSB and 200 µL aliquots of the 
culture supplemented with antibiotic were loaded in wells of a microtiter plate. As 
controls, untreated wells, and wells supplemented with solvent or polymer, were set. 
Bacterial growth was monitored for 24 hours at 37°C using a 96-well plate TECAN 
Genios Pro spectrophotometer (Tecan, UK). The minimum inhibitory concentration 
(MIC) was defined as the antibiotic concentration where no visible bacterial growth was 
observed or the OD600 was <10 % compared to the untreated control after 24 h of 
antibiotic exposure. 
 
Cellular Uptake Study  
Oregon-green loaded P31 unimolecular micelles were prepared by mixing 0.10 mL of 
a 100 mg/mL P31 solution in THF with 0.03 mL of a 28 mg/mL solution of Oregon-
green in DMSO - molecular ratio of 1:3 - and introduced into 10 volumes of deionized 
water under vigorous stirring. The solution was purified by dialysis for three days 
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against 5.00 L of deionized water using a cellulose dialysis membrane (Thermofisher, 
cut-off 3500) to remove the organic solvents and the free Oregon-green. The solution 
was then sterilized by filtration (0.22 µm, Millipore filters). 
 
Protocol I:  
THP-1 cells (3 × 105 cells per well) were differentiated in an 8-well glass bottom µ-slide 
(ibidi, Germany) for 24 h at 37 °C, 5 % CO2. Cell medium was removed and cells were 
then treated with fresh medium containing Oregon-green (100 µg/mL) loaded P31 
unimolecular micelles and incubated for 1 hour.[208] Cell culture medium was removed; 
cells were washed with PBS (twice) and incubated with CellMaskTM deep red plasma 
membrane stain (1.00 µg/mL, life technologies) for 15 minutes at 37 °C, 5 % CO2. After 
removing the solution, cells were washed with PBS (twice) and fixed with 4 % 
paraformaldehyde for 20 min at room temperature. After removing the solution, cells 
were washed with PBS (twice) and incubated with Hoechst 33342 dye (1.00 µg/mL, 
ThermoFisher) for 10 minutes to label the cells nuclei. After removing the solution, cells 
were washed with PBS (twice), covered with PBS and examined using examined using 
a Carl Zeiss LSM 700 BW microscope. 
 
Protocol II:  
THP-1 cells (3 × 105 cells per well) were differentiated in an 8-well glass bottom µ-slide 
(ibidi, Germany) for 24 h at 37 °C, 5 % CO2. Cell medium was removed and cells were 
then treated with fresh medium containing Oregon-green (100 µg/mL) loaded P31 
unimolecular micelles and incubated for 1 hour.[208] Cell culture medium was removed; 
cells were washed with PBS (twice) and fixed with 4 % paraformaldehyde for 20 min 
at room temperature. After removing the solution, cells were washed with PBS (twice) 
and incubated with Hoechst 33342 dye (1.00 µg/mL, ThermoFisher) for 10 minutes to 
label the cells nuclei. After removing the solution, cells were washed with PBS (twice) 
and incubated with Alexa FluorTM 647 Phalloidin (1.00 µg/mL, ThermoFisher) for 30 
minutes to label the cells F-actin. Cells were washed with PBS (twice), covered with 
PBS and examined using a Carl Zeiss LSM 700 BW microscope. 
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Synthesis of Oregon-green 28[209] 
 
Scheme 39: Synthesis of Oregon green 28.[209] 
 
4-Fluororesorcinol 26 (254.5 mg, 1.98 mmol) was dissolved in concentrated 
methanesulfonic acid (2.00 mL) and deoxygenated using nitrogen gas for 30 minutes 
before adding 1,2,4-benzenetricarboxylic anhydride 27 (254.5 mg, 1.32 mmol). The 
reaction mixture was heated at 80°C under nitrogen for 48 h. The mixture was then 
cooled down to room temperature and dropped into 7 volumes of ice water. The 
precipitate was recovered by filtration and dissolved in a small amount of methanol and 
precipitated again from cold water. The solid was subsequently freeze-dried and then 
purified by silica column chromatography (n-hexane/ethyl acetate = 1:1 – 0:1) to yield 
Oregon-green 28 as an orange solid (370.5 mg, 68 %). Rf = 0.33 (ethyl acetate). 
1H NMR (CDCl3, 400 MHz) δ (ppm) = 6.50 (s, 2H, CHad), 6.87 (s, 2H, CHkg), 7.78 (d, 
J = 8.0 Hz, 1H, CHz), 8.11 (d, J = 8.0 Hz, 1H, CHu), 8.39 (s, 1H, CHr), 8.64 (s, 1H, OH); 
13C NMR (CDCl3, 101 MHz,) δ (ppm) = 106.12 Ca, 114.12 Cd, 114.34 Ck, 114.40 Cg, 
126.27 Cz, 127.18 Ci, 127.97 Cr, 128.35 Cp, 129.51 Ct, 131.00 Cu, 132.38 Cn, 
133.14 Co, 136.34 Ce, 136.92 Cbc, 150.63 Cjf, 170.05 Csq, 187.99 Cm; MS (ESI-TOF): 
m/z [C21H10F2O7H]+ calc. 413.04, found 413.04; [C21H10F2O7]- calc. 411.04 found 
411.03. 
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7. ABBREVIATIONS AND SYMBOLS 
 
 
°C degrees Celsius 
ACN acetonitrile 
ADMET acyclic diene metathesis 
AFM atomic force microscopy 
ATRP atom transfer radical polymerization 
Az Azithromycin 
calc. calculated 
cat. catalyst 
CDI carbonyldiimidazole 
cm centimeter 
d deuterated, days 
Đ dispersity 
DCM dichloromethane 
dd doublet of doublets 
DLS dynamic light scattering 
DMPA 2,2-dimethoxy-2-phenylacetophenone 
DMSO dimethyl sulfoxide 
DPn number-averaged degree of 
polymerization 
DSC differential scanning calorimetry 
e.g. for example 
eq. equivalent 
ESI-MS electrospray ionization mass 
spectrometry 
et al. and others 
EVAc ethylene-vinyl acetate 
EWG electron-withdrawing groups 
FAB fast atom bombardment 
g gram 
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GC gas chromatography 
GPC gel permeation chromatography 
h hours 
Hz hertz 
HPLC high-performance liquid chromatography 
HRMS high resolution mass spectrometry 
ICTA irreversible chain transfer agent 
IBX 2-iodoxybenzoic acid 
i.e. id est (that is) 
IMCR isocyanide-based multicomponent 
reaction 
IR infrared 
k capacity factor 
K Kelvin 
kDa kilo dalton 
m meter, multiplet 
max maximum 
mCPBA 3-chloroperbenzoic acid 
MCR multicomponent reaction 
mg milligram 
MIC minimum inhibitory concentration 
min minute 
mL milliliter 
mm millimeter 
mmol millimole 
Mn number average molecular weight 
MPS mononuclear phagocyte system 
Mw weight average molecular weight 
n normal 
nm nanometer 
NMP nitroxide-mediated polymerization, N-
methyl-2-pyrrolidone 
NMR nuclear magnetic resonance 
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ox. oxidized 
Passerini-3CR Passerini three-component reaction 
Passerini-3CP Passerini three-component 
polymerization 
Passerini-3KR Passerini-Dreikomponentenreaktion 
PBS phosphate-buffered saline 
PEG polyethylene glycol 
PDI polydispersity index 
pol polymer 
ppm parts per million 
q quartet 
R variable functional group 
rad radiation 
RAFT reversible addition-fragmentation chain 
transfer 
Rf retarding-front 
ROMP ring-opening metathesis polymerization 
ROP ring-opening polymerization 
RP-HPLC reverse phase high-performance liquid 
chromatography 
rt room temperature 
s second, singlet 
SEC size exclusion chromatography 
T temperature 
t triplet, retention time 
TEM transmission electron microscopy 
Tg glass transition temperature 
THF tetrahydrofuran 
TLC thin layer chromatography 
Tm melting transition 
Ugi-4CR Ugi four-component reaction 
Ugi-5CR Ugi-five component reaction 
UCST upper critical solution temperature 
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UV ultraviolet 
VIS visible 
wt% percentage by weight 
Xn degree of polymerization 
δ phase shift, chemical shift 
µg microgram 
µm micrometer 
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